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Meeting report of the European Histamine Research Society
G. Sturman
Last year’s meeting in Sochi, Russia was the most eastern
meeting we have ever held whilst this year’s meeting (the
41st meeting of the European Histamine Research Society)
was the most westerly one. We met in Belfast, Northern
Ireland at the kind invitation of Professor Madeleine Ennis
of Queen’s University Belfast. This was the second joint
meeting with COST Action 0806—see following article.
These meetings took place in the Hilton Hotel, Belfast
(2nd–5th May 2012). This was the first time we have ever
met in Northern Ireland and we were situated right in the
centre of Belfast beside the River Lagan and not far from
the famous Harland and Wolff shipyards and the newly
opened Titanic Exhibition Museum.
This year over 130 delegates attended representing 29
countries (most from the European countries, especially the
UK but also from North and South America, Middle East,
Australia and Japan). Some of the regular EHRS attendees
could not attend and they were missed but a big welcome
was given to all the new visitors, who we hope will return
to future meetings. Most delegates arrived during the
Wednesday. As usual the Council held their meeting late
afternoon. Then there was a meeting for the COST BM
0806 WG 1 before our Welcome Reception; a delightful
buffet with plenty of wine and fruit juices to drink. Old
friends were greeted again whilst new ones were made.
On the Thursday, we began the meeting with the
Opening Ceremony. We started with an introduction from
our host Madeleine Ennis who informed us that ‘There
were no strangers present—just friends we have not yet
met!’ Then the Pro-Vice Chancellor for Research and
Postgraduates at Queen’s University Belfast, Professor
James McElnay welcomed us to QUB and Northern Ire-
land. He spoke about the beginning of QUB in 1845 and
gave an overview of the history and facilities within this
University. Then our president, Anita Sydbom gave her
welcoming talk, which centred round Irish folk customs,
especially the folk dances and costumes. She then outlined
the programme of this year’s meeting. She then presented
the student bursaries; certificates and cheques (each for
€500) to nine student members. The society is very grateful
to the El-Sayed Assem family for sponsoring 2 student
bursaries while the G.B. West Memorial Trust gave
another and the remaining six were from our society. This
was followed by the presentation of certificates to 16
COST BM0806 Early Stage Cost researchers. Then there
was the presentation of Honorary Membership to two of
our very special members; first to Professor Zsuzsanna
Huszti (Budapest, Hungary) and then to Professor Helmut
Haas (Dusseldorf, Germany). Anita gave the laudation to
Zsuzsanna and Patrizio Blandina (Italy) to Helmut. Both
Zsuzsanna Huszti and Helmut Haas have made significant
contributions to our society in many different ways over
the years. They were presented with a certificate beauti-
fully written in Latin and sporting the society’s official
seal. Then we heard the first of our plenary lectures. This
was given by Holger Stark (Germany) and was entitled
‘Histamine H4 receptor—ligand, binding and activation’.
Then at the start of our coffee break, we had a group
photograph taken. This was followed by the Walter Schu-
nack Memorial Symposium in which Holger Stark started
by giving an appreciation to Walter. This was followed by
4 oral presentations on the chemical aspects of histamine
receptor ligands. All the presenters gave very positive
references to Walter, his work and support and also to his
wonderful sense of humour. Continuing our tradition, each
oral session at this meeting was chaired by an experience
scientist as well as a young EHRS member so that they
could get experience of chairing oral sessions.
Then we quickly moved outside to get the coaches for
our outing. We drove along the northern side of the Belfast
Lough to Carrickfergus Castle, where we stopped to
explore this 800 year old castle. Participants could be seen
climbing up on the battlements and visiting the various
castle rooms. Then we continued along the Causeway
Coastal route which hugs the narrow strip of coastline
between the sea and the high cliffs. We passed through
some picturesque towns and villages and saw some spec-
tacular scenery, even sighting Scotland on the horizon as
well as Raithin Island. Finally we reached Northern Ire-
land’s most famous World Heritage Site, the Giant’s
Causeway, which was formed over 60 million years ago,
when molten lava cooled suddenly on contact with water
producing stone ‘benzene ring’ columns! Most people
made their way down to actually clamber over the Giant’s
Causeway. Then after warming ourselves up with hot
drinks we continued inland to Ballymena and the Galgorm
Hotel. Here we were made very welcome and had a won-
derful evening meal in this spectacular manor house.
During our dinner, we were entertained by 2 talented Irish
musicians from the band Pure Blarney singing and playing
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the guitar, tin whistle and bagpipes. We all agreed that it
was an excellent end to the first day of our meeting.
Friday began with the G.B. West lecture which was
given by Peter Bradding (Leicester University, UK) and
was entitled ‘Interactions between mast cells and structural
airway cells in the pathogenesis of asthma’. This was fol-
lowed by poster sessions on ‘Histamine and the Nervous
System’ and ‘Mast cells, Metabolism and Chemistry’. Then
we listened to three lectures on ‘Novel highlights on mast
cell functions’ (COST BM 1007). After lunch, like last
year, we held a Round Table which was entitled ‘What’s
new in H4 research? (COST BM 0806). Robin Thurmond
(USA) lead a panel of histaminologists which included
Elena Rivera (Argentina), Paul Chazot (UK), Ralph
Gutzmer (Germany) and Hoger Stark (Germany) and
needless to say this resulted in lively discussions. After the
afternoon break, there was an oral session on ‘Mast cells
and Inflammation’ followed by another one on ‘Clinical
aspects of the H4 receptor’ (COST BM0806). Then the
WG3 COST Action BM0806 took place. After our evening
meal, we took part in some Irish Whiskey Tasting. We
were informed that whiskey was the ‘Water of Life’ and
that Irish whiskey differed from Scotch as it was distilled
three times rather than just twice. This thus gives Irish
whiskey a much smoother taste. As predicted, there was
much fun involved with this activity.
Our final plenary lecture by Beatrice Passini (Florence,
Italy) started our Saturday’s meeting. Her lecture was
entitled ‘H4R and neuroinflammation: insights from mouse
experimental autoimmune encephalomyelitis’ and she gave
a very interesting lecture despite the projector not showing
the true colours of her histopathology results. This lecture
was followed by an oral session on ‘Histamine and the
Nervous System’. After our coffee break, we viewed the
poster presentations on ‘Histamine—H4 receptor’ and also
‘Clinical aspects and cellular studies’.
Throughout the meeting the poster committee had been
working very hard and as usual had a difficult task in
identifying winning posters for the poster competition.
Eventually first prize was given to F. Jantzen et al. from
Hannover, Germany, second to S. Micallef et al.,
from Dublin, Ireland and third prize to L. Kay et al., from
Sheffield, UK.
The final oral session of our meeting was to listen to
our younger members (PhD students or not more than
3 year’s post-doctoral research) give their presentations
for the EHRS Young Investigators Award. Regrettably
one student had withdrawn at the last minute. It was
another difficult task for the judges in differentiating
between these four excellent presentations. The winner
was Gustavo Provensi (Florence, Italy) with Naresha
Saligrama (Vermont, USA) and Tomas Perecko (Brati-
slava, Slovakia) sharing joint second place and Yan Zhao
(Lyon, France) being highly commended. To summarise
the COST Action BM0806 work, Katherine Tiligada
(Athens, Greece) told us about the ‘Progress and Limita-
tions in H4R research.’ Then we held our General
Assembly. According to our statutes, a new Council had
to be elected and after a ballot, Nick Carruthers (USA),
Jian-Sheng Lin (France), Beatrice Passani (Italy) and
Astrid Sasse (Ireland) were duly elected to serve on our
Council. Additionally Anita’s second and last term of
office as President has now finished. Paul Chazot (Dur-
ham, UK) was unanimously elected as our new President.
Many thanks were given to Anita for all her hard work to
the society over the last 6 years. Our meeting ended with
its traditional excellent Farewell Dinner followed by our
award ceremony. The certificates and prizes were given
out. Then as usual we had our singing session, beginning
with ‘‘Anita’s Thank You Song’’ (sung to the tune of
‘It’s a long way to Tipperary’) as a big thank you to
Madeleine and her team for the excellent meeting, and
then we sung our EHRS Anthem. Afterwards ‘Haste to
the Wedding’ played for us and we had a go at some
Irish Ceilidh dancing—great fun was had by all.
We all agreed that the Northern Irish team, especially
Madeleine had hosted a very well organised meeting with
excellent science. Our thanks were given to all of them.
The next meeting will be held in Lodz, Poland (8–11 May,
2013) at the kind invitation of Agnieszka Fogel.
Participants of the 2012 meeting of the EHRS
Department of Pharmacology and Therapeutics, School
of Biomedical and Health Sciences, Kings College London,
London, SE1 1UL, UK. E-mail: gill.sturman@virgin.net
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Honorary Memberships in the European Histamine Research Society
P. Blandina, A. Sydbom, H. Haas, G. Sturman
There are three types of membership in the EHRS: ordin-
ary, corporate and affiliated, and honorary (life). The
highest award is that of honorary membership which is
only given to very special people. To obtain honorary
membership, the person has to be elected by over two-
thirds of the ordinary members at the General Assembly.
There are only 10 current Honorary Members of the
Society; Madeleine Ennis, Robin Ganellin, Wilfried
Lorenz, Piero Mannaioni, Bruno Mondovi, Fred Pearce,
Henk Timmerman, Ingrid Olhagen-Uvnäs, Takehiko
Watanabe and Jean West. Our former Honorary Members
include Sir James Black, Franc Erjavec, Jack Peter Green,
Czeslaw Maslinski, Wolfgang Schmutzler, Walter
Schunack, Börje Uvnäs and Geoff West. At this meeting,
the society awarded Honorary Membership to two special
people who have both contributed significantly to the EHRS;
they are Professor Zsuzsanna Husti and Professor Helmut
Haas.
The oration for Professor Zsuzsanna Husti was given by
our President, Anita Sydbom. Zsuzsanna Huszti, of the
famous Semmelweis University in Budapest, Hungary, was
born on the 16th of March 1936 in Szeged. In 1954 she
entered the University of Szeged in the faculty of Natural
Sciences where she studied chemistry. After getting her
diploma in chemistry 1959, she worked as a research
assistant at the Central Research Laboratory of the Szent-
Györgyi Albert Medical School in Szeged. In 1962,
Zsuzsanna started her doctorate work in biochemistry at the
Eötvös József University, Budapest. At that time she also
had a position as clinical chemist in the Central Hospital,
Gyula, and as a research assistant at the Department of
Pharmacology in the Drug Research Institute, Budapest.
From 1971 to 1981 she was head of the Radioactive Lab-
oratory at the Department of Biochemistry, Drug Research
Institute, Budapest. From 1997 she became the head of the
Neurobiobiology Unit in the Department of Pharmacody-
namics, Semmelweis University of Medicine, Budapest.
Although her first publication was in 1963, her first one
on histamine was in 1967 and her Ph.D. thesis (1972) was
entitled ‘‘Heterogeneity of monoamine oxidase in rat
brain’’. This was followed by postdoctoral position in the
Department of Neurobiology, at McGill University, Mon-
treal, Canada working with Professor Theodore L. Sourkes.
This resulted in a fruitful collaboration and many papers
about histidine metabolism. In 1994 Zsuzsanna produced a
second thesis; this time for Doctor of Biological Science
degree. This thesis was entitled ‘‘Histamine in the nervous
system: regulation of histamine synthesis and function in
the brain’’. She has published over 75 publications; most
are concerned with histamine. She is/was a member of
several scientific societies, namely the Hungarian Society
of Biochemistry, International Society for Neurochemistry
(ISN), Hungarian Pharmacological Society, European
Society for Neurochemistry (ESN), International Brain
Research (IBRO) and New York Academy of Sciences plus
our society.
Zsuszanna Huszti has had a long standing connection
with the EHRS. She was invited by Professor Maslinski,
who had read her articles, to the very first informal meeting
of the ‘Histamine Club’ held in Lodz, Poland 1971. After
this meeting she has visited 36 EHRS meetings in total.
She was the EHRS National Secretary for Hungary from
1972 to 2000. She gave an EHRS Invited Lecturer at the
meeting in Eger (2004) with the title: Histamine uptake by
non-neuronal cells of the brain: properties and function.
She brilliantly organized two unforgettable EHRS meet-
ings in Hungary, the 9th EHRS Meeting 1980 in Visegrad
and the 23rd EHRS Meeting 1994 in Budapest. Many
pictures from the different EHRS meeting can be seen
under Previous Meetings on our website http://www.
EHRS.org.uk. Zsuzsanna Huszti has for many years been
devoted to our society, interested in science and young
researchers and always is putting interesting questions to
the speakers at our meetings. So with this it is a great
honour to present the EHRS Honourary Membership to
Zsuzsanna Huszti.
The oration for Professor Helmut Haas was given by
Professor Patrizio Blandina. Helmut grew up in the south-
west corner of Germany. After naval military service he
studied medicine in Basel, Switzerland and Freiburg, Ger-
many, where he obtained his M.D. (1968) for a dissertation
on aphasia. Then he worked in the Psychiatric and Neuro-
logical University—Clinics in Basel before taking a
postdoctoral position in the Department of Pharmacology,
Cambridge, England. This was followed by a number of
years as head of the Neurophysiology-Laboratory in the
Neurosurgery-Department Zürich and visiting Professor-
ships on sleep research at Harvard-University in 1986 and
1989. In 1987 Helmut became Professor and Head of
the Department of Biophysics at Johannes-Gutenberg-
S40 The European Histamine Research Society
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Universität Mainz, Germany; in 1991 he took the Chair of
Neurophysiology at Heinrich-Heine-Universität Düsseldorf.
In 1971 Helmut began to work on histamine in the
brainstem. He has since devoted much of his scientific life
to this fascinating field characterizing histamine actions in
the brain (e.g. Nature 1975, 1983, Neuron 1993) and later
the properties of histaminergic neurons in the tubero-
mamillary nucleus using mainly electrophysiological
methods. He has published over 200 peer-reviewed papers
and serves on the editorial boards of several journals. His
research was financed by the National Institutions in
Switzerland and Germany and the Human Frontiers Sci-
ence Programme (network mechanisms of memory trace
formation) as well as the European Community (Consor-
tium ‘‘food, mood and sleep’’ on orexins). Helmut, besides
being a regular attendee of our meetings, hosted the 33rd
EHRS meeting in 2004 near Düsseldorf. He is now, retired
but not tired, cooperating with his wife (Prof. Olga
Sergeeva) on new challenges of the histaminergic system
in the brain. Helmut truly deserves the accolade of being
elected an Honorary Member of this society.
Helmut Haas, Anita Sydbom (President) amd Zsuzsanna Huszti at the
Farewell Dinner
Department of Pharmacology and Therapeutics, School
of Biomedical and Health Sciences, Kings College London,
London, SE1 1UL, UK. E-mail: gill.sturman@virgin.net
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Meeting Report of the Cost Action BM0806 ‘Recent advances in histamine
receptor H4R research’
E. Tiligada
The main 2012 meeting of COST Action BM0806 ‘Recent
advances in histamine receptor H4R research’ was hosted
by Madeleine Ennis (Secretary of the Action, The Queen’s
University of Belfast, UK) and took place jointly with the
41st Annual EHRS conference held in the Hilton Belfast
hotel, UK. The key objective of the Action BM0806 is to
foster a multidisciplinary approach to histamine H4
receptor (H4R) research and to focus on the current state of
play pertaining to the basic understanding and the huge
therapeutic potential of this new drug target. The Action
builds up strong European interdisciplinary links among
more than 150 senior and young scientists from at least 40
research groups based on 20 COST (AT, CH, CZ, DE, DK,
EL, ES, FI, FR, HU, IE, IL, IT, LT, NL, PL, SE, SI, SK,
UK) and 4 non-COST (AR, NZ, US, RU) countries, who
actively participate in the 4 mutually interlocking working
Groups (WG) of the Action.
H4R is the most recently identified histamine receptor
subtype, which is primarily linked to immunomodulation
and to a variety of inflammatory disorders. The develop-
ment and the evaluation of selective H4R ligands aim to
promote the translational perspective in this field of
research. COST Action BM0806 has a firm foundation for
managing research into the H4R function and therapeutic
potential due to the combined efforts of scientists from
multiple disciplines including biochemistry, molecular and
cellular biology, genetics, chemistry, bioinformatics, phar-
macology and medicine. Members of the COST Action are
dominating the publications in this area, thus making Eur-
ope the leader in the field. This joint conference enhanced
the previously established links with the EHRS, while the
rapid and productive result dissemination and the direct
exchange of ideas will enable the expert teams to work more
efficiently towards the potential exploitation of this new
drug target. Additionally, a delegate from Japan, the major
non-COST country where H4R research outside BM0806 is
pursued, applied to join the Action. Importantly, the train-
ing of Early Stage Researchers (ESRs) in all aspects of H4R
research was broadened and their mobility by using the
Short-Term Scientific Mission (STSM) COST tool was
stimulated and encouraged during this joint activity.
The COST conference attracted 58 Action members
from 22 member countries and comprised 3 COST Plenary
Lectures, 2 COST sessions with 13 oral presentations and
14 peer-reviewed posters (5 related to STSMs), a round
table session, a guest symposium from members of the
COST Action BM1007, which concentrates on mast cell
and basophil function, a BM0806 Management Committee
meeting and WG1, 2, 3 & 4 meetings. In keeping with the
tradition started at the Durham meeting in 2010, symposia
and poster sessions were nearly all co-chaired by ESRs
together with senior scientists. Sixteen ESRs received
awards for their contribution to H4R research, while the
winner and the 2nd prize winner in the poster competition
of this Joint meeting were both Action member ESRs
(Franziska Jantzen, Hannover Medical School, DE;
Stephanie Micallef, Trinity College Dublin, IE). In the
Young Investigator Award, Tomáš Perečko (Slovak
Academy of Sciences, SK) received joint 2nd prize as a
result of the work that he performed during a COST
BM0806 STSM.
An elegant description of H4R ligands and the approa-
ches for lead development was provided by Holger Stark
(Goethe University, Frankfurt, DE). The data on the char-
acterization of the H4R binding pocket by molecular
dynamics simulations and the binding properties of H4R
agonists, inverse agonists and neutral antagonists will be of
immense use to the members of the COST Action. New
information was provided by Beatrice Passani (University
of Florence, IT) on the involvement of the H4R in neuro-
inflammation and in particular in a mouse model of
multiple sclerosis. Strategies aimed at interfering with the
histamine axis may have relevance in the therapy of
autoimmune diseases of the central nervous system (CNS)
as histamine may determine a shift in T helper cell sub-
population, influence migration of lymphocytes and
myeloid cells during CNS invasion, interfere with antigen
presentation at the immune synapse level and determine
variations in normal neuronal functions. During the guest
symposium of the COST Action BM1007, Uli Blank (In-
serm U699, FR) proposed the late signalling events in mast
cell degranulation as a novel target for the development of
drugs to block mediator release; Gunnar Nilsson (Karo-
linska Institutet, SE) reported on the secretion of large
variety of oxylipins by mast cells and Francesca Levi-
Schaffer (The Hebrew University of Jerusalem, IL)
described the interactions between mast cells and eosino-
phils, which serve to perpetuate the inflammatory response.
S42 The European Histamine Research Society
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The following highlights of the COST Action BM0806
presentations show the advancements on H4R research.
Rob Thurmond (Johnson & Johnson, US) offered insights
on the interaction between H4R and TLR activation in
vivo, which can drive inflammatory responses. Arianna
Rosa (ESR, University of Turin, IT) suggested a novel use
for H4R blockers in pulmonary fibrosis and also showed
that the H4R expressed in the kidney is up-regulated in
diabetic male rats. Tomáš Perečko provided novel infor-
mation on the presence of H4Rs in human neutrophils and
on their involvement in the inhibition of neutrophil
degranulation. Interestingly, Maristella Adami (University
of Parma, IT) reported on the effective inhibition of car-
rageenan-induced oedema by H4R agonists rather than
antagonists. Spyridon Chalkiadakis (ESR, University of
Athens Medical School, EL) provided further evidence on
the putative constitutive H4R-mediated automodulatory
histamine function in the rat conjunctiva using novel 2,4-
diaminopyrimidine derivatives targeting the receptor. The
presence of H4Rs on peptidergic Ad fibres (CGRP) and
C-fibres (substance P) reported by Mwape Katebe (ESR,
University of Durham, UK) could have implications not
only in chronic pain but also in chronic cough, while evi-
dence provided by Diego Martinel Lamas (ESR, University
of Buenos Aires, AR) pointed to the potential therapeutic
use for H4R agonists in the treatment of breast cancer.
Novel approaches to H4R research were presented by
Gniewomir Latacz (ESR, Collegium Medicum Jagiellonian
University, PL) who found that some N-methylpiperazine
derivatives influenced the motility of the promoter of
PTEN, one of the most frequently mutated tumor
suppressor genes in human cancer as well as by Anwar
Rayan (GeneArrest, IL) who described the methods used to
alter H4R gene expression by novel and highly specific
molecules which bind tightly and selectively to predeter-
mined sequences in the major groove of double stranded
DNA. Hubert Schwelberger (Medical University Inns-
bruck, AT) provided information on the progress of the
histamine methods and tools database (HMTD), which will
be of immense use to all working in the field. Finally, the
Action Chair Katerina Tiligada (University of Athens
Medical School, EL) presented an overall update on current
H4R research, emphasising that a large body of evidence
identifies the H4R as a central player in initiating and
propagating immune responses, yet the variability in H4R-
mediated signals and in the pharmacological properties of
H4R ligands has to be carefully considered when charac-
terizing H4R functions in in vivo models of disease and
translating preclinical data to clinical human settings.
Overall, this joint COST Action BM0806/EHRS con-
ference attracted all the major players who have interest in
H4R-related research and drug development and it was
characterised by intense and fruitful discussions between
delegates, which are expected to meet the major challenges
in understanding the functional properties and the thera-
peutic potential of the H4R.
E. Tiligada
Department of Pharmacology,
Medical School, University of Athens,
11527 Athens, Greece.
E-mail: aityliga@med.uoa.gr
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PROGRESS AND LIMITATIONS IN H4R
RESEARCH
E. Tiligada
Histamine elicits pleiotropic actions largely through binding
to four currently known G protein-coupled receptors
(GPCRs), designated as H1R–H4R. The latest concept that
histamine exerts immunomodulatory actions in inflamma-
tion through H4R signalling and the potential exploitation of
this activity for a range of poorly treatable chronic inflam-
matory diseases are currently under worldwide evaluation.
Although the large body of evidence identifies the H4R as a
central player in initiating and propagating immune
responses, the cell and tissue variability in H4R-mediated
signals and the profound intra- and inter-species differences
in potency, selectivity and off-target effects of H4R ligands
hamper investigations and call for more cautious interpre-
tation of H4R-mediated effects in vivo. For instance, the
complex pharmacology of H4R ligands can be partly attrib-
uted to the functional selectivity exhibited by many GPCRs
under different experimental or physiological environments.
In this multifaceted system of immunoregulation further
experimental approaches are needed to address numerous
unresolved questions. For instance, what is the contribution
of the H4R in differentiating the phenotypes and chemotaxis
of immunocompetent cells in inflammation? What are the
molecular mechanisms underpinning H4R cross-talk with
immune-relevant pathways, such as TLR signalling and TH1/
TH2 polarisation, and how would these interactions be useful
in identifying more effective therapeutic targets for inflam-
matory diseases? Finally, it would be interesting to know
whether autocrine or paracrine mechanisms are in operation
considering that mast cells, the main histamine source in the
body, express histamine receptors. Establishing the benefi-
cial end-points of the histamine-mediated orchestration of
the complex immune response is an altruistic challenge of
EU RTD FP7 COST Action BM0806: Recent advances in
histamine receptor H4R research.
Department of Pharmacology, University of Athens
Medical School, 11527 Athens, Greece. E-mail: aityliga@
med.uoa.gr
H4R AND NEUROINFLAMMATION: INSIGHTS
FROM MOUSE EXPERIMENTAL AUTOIMMUNE
ENCEPHALOMYELITIS
M.B. Passani
The histaminergic system has been postulated to have a
role in the pathogenesis of autoimmune diseases and there
are several lines of evidence suggesting a key regulatory
role of histamine in the widely used murine model,
experimental autoimmune encephalomyelitis (EAE).
Therefore, strategies aimed at interfering with the hista-
mine axis may have relevance in the therapy of CNS
autoimmune disease. Given the distribution of the hista-
mine H4 receptor (H4R) on immune cells and its primary
role in inflammatory functions it has become a very
attractive target for the treatment of asthma and autoim-
mune diseases. Furthermore, recent evidence has shown the
topological and functional localisation of the H4R in the
CNS of both humans and rodents. However, the picture is
more complex than expected, as recent data showed that
the activation, and not the antagonism, of the H4R leads to
reduced pro-inflammatory capacity of a subpopulation of
dendritic cells found in inflamed tissues in atopic derma-
titis. Results from our laboratory are also pointing in this
direction, as H4R antagonists tested in EAE murine model
appear to exacerbate several parameters of the disease and
up-regulate H4R expression on T and dendritic cells in the
spinal cord of EAE mice. Accordingly, H4R KO mice
develop more severe EAE.
The complex and apparently controversial results sum-
marized here, on the one hand provide compelling
evidence that the H4R has multiple roles in the function of
various cellular elements that may be associated with
immune disorders. However, these observations challenge
the scientific community to develop the adequate treat-
ments for these pathological conditions.
Dipartimento di Farmacologia Preclinica e Clinica
50139 Firenze, Italy. E-mail: beatrice.passani@unifi.it
BEHAVIOURAL ANALYSIS OF H4 RECEPTOR
KNOCKOUT MICE
K. Rossbach, M. Bankstahl, W. Bäumer
Histamine is a well known neurotransmitter that is
involved in the regulation of many different brain functions
such as waking-sleep cycle, anxiety, cognition, learning
and memory as well as basic homeostatic functions. All
four histamine receptors (H1-4R) are located in the brain.
The expression of the H4R in the human and rodent brain
has only recently been reported and its functional role
remains to be elucidated. In this study a first set of
behavioural tests was performed twice with H4R knockout
mice in comparison to age-and sex-matched wild-type
mice (BALB/c) (4 male and 4 female mice per group). For
a general behavioural screen, a subset of tests from the
Irwin screen was performed (7 males and 10 females/
group). General physical characteristics or sensorimotor
S46 The European Histamine Research Society
123
reflexes showed no obvious abnormalities in the group of
H4R knockout mice. However, H4R knockout showed an
enhanced escape response to approach and struggled more
when touched or restrained by tail. For analysing the
general activity and anxiety-related behaviour, the open
field test, the light and dark box and the elevated plus maze
test were performed. Overall, the H4R knockout mice
showed only marginal differences in exploratory or anxi-
ety-like behaviour. Furthermore, spatial learning and
memory were tested in the Morris water maze test (10
females/group). The H4R knockout showed an apparent
improved performance in the Morris water maze test
compared to the poor performance of the wild-type mice in
this experimental setting. In summary, the H4R knockout
mice seem to react with hyperactivity to handling, but
showed no gross differences in other test parameters of the
Irwin screen or in their exploratory or anxiety-like behav-
iour. The apparent improved performance in the Morris
water maze test of the H4R knockout mice may be a first
hint for a better learning and memory behaviour of these
mice. Thus, the present study reveals that there are dif-
ferences in the behavioural phenotype of the H4R knockout
mice, but further studies are required to confirm these
differences and in more detail.
Supported by COST Action BM0806
Institute of Pharmacology, Toxicology and Pharmacy,
University of Veterinary Medicine Hannover, 30559 Han-
nover, Germany. E-mail: kristine.rossbach@tiho-hannover.de
SPECIFIC HISTAMINE H4 RECEPTOR
ANTAGONISTS ACT AS POTENT MODULATORS
OF MAMMAL VESTIBULAR FUNCTION
E. Wersinger, G. Desmadryl, S. Gaboyard-Niay,
A. Brugeaud, J. Dyhrfjeld-Johnsen, C. Chabbert
Histamine is a naturally occurring biological amine that
exerts a range of effects on many physiological processes
through the activation of four different G protein-coupled
histamine receptors (H1R-H4R). Besides their localization
in the immune system, H1-H4 receptors are also found in
the central and peripheral nervous systems. Recent work
has shown H3R expression in mammalian vestibular neu-
rons and has shown that their antagonist, betahistine,
routinely used in the treatment of vertigo can act periph-
erally by inhibiting the afferent discharge recorded from
the vestibular nerve in several species.
We aimed to further explore the expression and role of
H4R in Long Evans rat vestibular system by combining
RT-PCR and immunohistochemistry experiments, as well
as pharmacological and behavioral tests. Using this mul-
tidisciplinary approach we first confirmed the expression of
H1 and H3 receptors and further demonstrated the locali-
zation of H4R in primary vestibular neurons cytoplasmic
membrane. In vitro, whole cell patch-clamp recordings
from P4 to P7 cultured vestibular neurons revealed strong
and reversible inhibitory effects on evoked action potential
firing by H4R antagonists JNJ10191584 and JNJ7777120
with IC50 in the lmolar range (n [ 5 cells/concentration
tested). In vivo, the effect of these antagonists on experi-
mentally induced severe vestibular deficits were evaluated
in three different animal models using a rating system
based on multiple criteria: circling, head bobbing and head
tilt, tail hanging and air righting reflexes. Each H4R
antagonist significantly alleviated induced vestibular defi-
cits by 20–30 % (n [ 8 animals for control, sham and
treated conditions). By contrast, neither of the H3 receptor
antagonists tested as reference compounds had significant
effects.
This study demonstrates the role of H4R antagonists in
modulating vestibular function and suggests that they are
strong candidates for a novel, highly efficient treatment of
vertigo crisis caused by peripheral vestibular dysfunction.
SENSORION pharmaceuticals, Institute for Neurosci-
ences of Montpellier, 34090 Montpellier, France. E-mail:
eric.wersinger@sensorion-pharma.com
DIFFERENTIAL CHANGES IN H4R EXPRESSION
IN ACUTE AND CHRONIC INFLAMMATORY PAIN
MODELS
M. Katebe, N. Lethbridge, P.L. Chazot
The histamine H4 receptor is a G-protein coupled receptor
that is primarily expressed on cells involves in inflamma-
tion and immune responses such as eosinophils, mast cells,
dendritic cells and T-cells. It has been postulated to have
immunomodulatory functions in these cells such as acti-
vation, migration and production of chemokines and
cytokines.
Immunohistochemical studies from our laboratory and
others have revealed the expression of the receptor on
sensory neurons, small and medium sized diameter neurons
and lamina I and II of the spinal cord suggesting a potential
new target for the modulation of pain. The H4R antagonist
JNJ7777120, exhibits analgesic effects in Complete Fre-
und’s adjuvant (CFA) pain models.
The aim of the present study was to investigate the
changes in H4 receptor expression that occur in the acute
(24 h) and chronic (16 days) phases of Complete Freund’s
adjuvant induced inflammation as compared to non-treated
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animals (in collaboration with GSK (UK) and Pfizer (UK),
respectively). Our hypothesis was that H4 receptor protein
would be differentially altered during the acute and chronic
phases of inflammatory-induced pain.
Using our well validated anti-hH4 receptor antibody which
cross-reacts with rodent tissue, western blot analysis of skin
and spinal cord tissue samples obtained from CFA-induced
male Wistar rats, acute (n = 10) and chronic (n = 4)
inflammatory pain models showed an apparent upregulation
in the expression of H4 receptors at the skin but not the spinal
cord. In contrast, this apparent up-regulation was not observed
later in the chronic phase in the skin, and an apparent down-
regulation of expression was seen in the spinal cord. We are
currently formally identifying the cell types where these
changes are occurring, namely immune and/or neuronal. This
indicates both topological and temporal differences in H4R
expression occur in inflammatory pain states
School of Biological & Biomedical Sciences, Durham
University, DH1 3LE. Durham, UK. E-mail: m.a.katebe@
durham.ac.uk
ROLE OF HISTAMINE H4R IN BLEOMYCIN-
INDUCED PULMONARY FIBROSIS
A. Pini, D. Bani, M.B. Passani, R.L. Thurmond, H. Stark,
E. Masini
Pulmonary fibrosis is a progressive and lethal illness
characterized by inflammation and abnormal remodeling of
lung parenchyma. No cure exists for this disease. There are
various models used for the study of pulmonary fibrosis,
among these, the bleomycin one is the best characterized
murine model in use. Bleomycin alters oxidant/antioxidant
balance and ROS overproduction activates several intra-
cellular signaling pathways, leading to pro-inflammatory
cytokine production. The histamine H4R, expressed on cell
of immune origin, plays an important role in inflammatory
process. We previously demonstrated that JNJ7777120
(JNJ), a selective H4R antagonist, potentiates the beneficial
effect of naproxen in this experimental model. The aim of
the present study was to investigate the role of different
H4R ligands in controlling inflammation and pulmonary
fibrotic process induced by bleomycin. C57/bl6 mice were
treated with vehicle, JNJ (total dose 40 mg per Kg/bw) or
ST-1124 (partial inverse agonist), ST-1006 (partial agonist)
and ST-994 (neutral antagonist) at equimolar doses,
released by micro-osmotic pumps for 21 days. Airway
resistance to inflation, an index of lung stiffness, was
assayed and lung tissue processed to evaluate inflammation
and fibrosis. Our results indicate that JNJ and ST-994 exert
an anti-inflammatory effect, as shown by the significant
decrease in the levels of PGE2, MPO, an index of leukocyte
infiltration, and TBARS, markers of oxidative stress. They
also reduce the relative number of goblet cells, the thick-
ness of smooth muscle layer (parameters of inflammation-
induced adverse bronchial remodeling), the level of
pro-fibrotic cytokine (TGF-b) and collagen deposition;
these effects are accompanied by a decrease in airway
resistance to inflation. The compounds ST-1112, partial
inverse agonist and ST-1006, partial agonist, exerted a
modest effect on reducing inflammation and preventing the
fibrotic process.
Taken together our results indicated that H4R blockade
is associated with an anti-inflammatory and anti-fibrotic
effect and may offer a new therapeutic option for the
treatment of Th2-dependent lung inflammatory disease.
Supported by COST Action BM0806.
Department of Preclinical and Clinical Pharmacology,
University of Florence, Viale G. Pieraccini n.6, 50139
Florence, Italy. E-mail: emanuela.masini@unifi.it
ANTAGONISM OF THE HISTAMINE H4
RECEPTOR REDUCES LPS-INDUCED TNF
PRODUCTION IN VIVO
J.M. Cowden, F. Yu, M. Challapalli, J.-F. Huang,
W.-P. Fung-Leung, J.Y. Ma, J.P. Riley, M. Zhang,
P.J. Dunford, R.L. Thurmond
Antagonism of the histamine H4 receptor (H4R) has been
shown to be anti-inflammatory in a number of preclinical
disease models, however the exact mechanisms behind this
are still being uncovered. In vitro, the receptor has been
shown to interact with TLR and impact inflammatory
mediator production from a number of different cells types.
Here it is shown that this interaction can also occur in vivo.
Two different H4R antagonists, JNJ 7777120 and JNJ
28307474, inhibited LPS-induced TNF production in mice.
Furthermore, this production was also reduced in H4R-
deficient mice. TNF mRNA analysis showed that the major
source of the cytokine was the liver and not blood, and that
the H4R antagonist only reduced the expression levels in
the liver. The inhibition was only observed with in vivo
administration of both the H4R antagonists and LPS sug-
gesting that the effect is mediated by tissue resident cells.
In support of this conclusion, depletion or inactivation of
macrophages reduced the TNF levels and eliminated the
H4R sensitivity. Treatment with an H4R antagonist also
reduced LPS-induced liver injury and blocked LPS-
enhanced lung inflammation in mice. In conclusion, the
data support an interaction between H4R and TLR activa-
tion in vivo which can drive inflammatory responses.
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Janssen Research and Development, L.L.C. San Diego,
CA 92121, USA. E-mail: rthurmon@its.jnj.com
THE HISTAMINE H4 RECEPTOR BLUNTS
NEUTROPHIL DEGRANULATION
BY PREVENTING BETA 2 INTEGRIN-DEPENDENT
SIGNALLING
T. Perecko, V. Brown, D. Comer, R. Thurmond, K. Dib,
M. Ennis
Histamine is a biogenic amine implicated in allergic
asthma. In the airways, its main targets are eosinophils,
smooth muscle and the endothelium. There are 4 types of
histamine receptors (H1R, H2R, H3R, and H4R). All
belong to the G protein-coupled receptor family. Hista-
mine has also been shown to regulate the functions of
other immune cells including neutrophils. However, little
is known on the nature of the histamine receptors involved
in the regulation of neutrophil functions. We investigated
whether the H4R regulates beta2 integrin-dependent
adhesion and degranulation in human neutrophils.
Neutrophils were isolated from blood by Dextran sedi-
mentation and centrifugation through Ficoll-Hypaque.
Neutrophils adherent to fibrinogen (a ligand for beta2
integrins) were stained with crystal violet and the OD of
the eluted dye was read using a spectrophotometer.
Degranulation was assessed by ELISA by measuring the
release of lactoferrin. The chemoattractant fMLP (10-7 M)
induced a beta2 integrin-dependent adhesion and degran-
ulation of human neutrophils. In contrast, histamine by
itself did not have such an effect. However, histamine
(10-6 M) blocked fMLP-induced adhesion-dependent
degranulation of human neutrophils by ca. 60 %. The H4R
agonist JNJ28610244 (10-5 M) reduced release to ca.
38 % of fMLP alone. Moreover, the H4R antagonist
JNJ7777120 prevented the inhibitory effect of histamine
on neutrophil degranulation. Interestingly, neither hista-
mine nor the H4R agonist JNJ28610244 blocked fMLP-
induced beta2 integrin-dependent neutrophil adhesion
indicating that histamine did not interfere with the
expression or change of conformation of beta2 integrins
induced by the chemoattractant fMLP. Our results dem-
onstrate for the first time that the H4R blocks neutrophil’s
anti-microbial functions.
Supported by a STSM from COST Action BM0806. The
work has been awarded a Young Investigators Award by
the EHRS 2012.
Centre for Infection and Immunity, Queen’s University
Belfast, Belfast, BT9 7BL, UK. E-mail: k.dib@qub.ac.uk;
m.ennis@qub.ac.uk
H1 VERSUS H4 ANTI-HISTAMINES IN HUMAN
NEUTROPHIL OXIDATIVE BURST
R. Nosal, K. Drabikova, V. Jancinova, T. Perecko,
A. Lojek, M. Ciz, J. Kralova
Professional phagocytes play a crucial role in phagocytosis,
immune reactions and pathological processes, including
inflammation. Histamine possesses a regulatory role in
these reactions. We found that H1R anti-histamines (AH)
inhibited the oxidative burst of professional phagocytes
according to their chemical structure and physico-chemical
properties. In this study, we compared the effect of H1R
and H4R AH on the oxidative burst of human blood and
isolated neutrophils by means of luminol and/or isoluminol
enhanced chemiluminescence (CL) in vitro. Thirteen
compounds of the 1st and 2nd H1R AH generation, and
JNJ7777120, JNJ10191584 and thioperamine, H4R AH
were analysed. Most of the H1R AH tested dose-depen-
dently inhibited stimulated CL produced by neutrophils.
Histamine was effective only at the extracellular level. H1R
AH inhibited CL both at extracellular (scavenging) and
intracellular level of neutrophils (suggestive of interference
with regulatory enzymes). It is expected that the inhibition
is a result of nonreceptor rather than receptor interaction.
The H4R AH JNJ7777120 and JNJ10191584 tested showed
very weak inhibition on whole blood and extracellular CL,
without any dose–response relationship and they were not
active intracellularly. Thioperamide potentiated CL both in
whole blood and in isolated neutrophils. The difference
between H1R and H4R AH effect on oxidative burst
requires further analysis at the molecular level and through
structure–activity relationship. In comparison with H1R
AH, the H4R AH compounds tested displayed a very low
scavenging and intracellular antioxidative and oxidative
burst suppressing activity.
Supported by projects VEGA 2/0003/07, APVV
0315-07 and 0052-10 and COST BM0806.
Institute of Experimental Pharmacology SAS, 88104
Bratislava, Slovakia. E-mail: exfarano@savba.sk




M. Adami, G. Coruzzi, R. Smits, H. Lim, R. Leurs
The paradigm that the histamine H4 receptor (H4R)
blockade is related to inhibition of inflammation has been
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challenged by the recently reported agonist activity of
JNJ7777120, the ‘‘standard’’ H4R antagonist, in some
settings. This is in line with previous observations from our
lab, which showed anti-inflammatory effects of the H4R
agonists VUF8430 and VUF10460 on carrageenan-induced
paw edema in the rat.
In the present study, several H4R ligands were charac-
terized for their H4R activity (agonism, partial agonism,
neutral antagonism) using the rat GTPcS binding assay and
tested in vivo against carrageenan-induced paw edema in
the rat.
Among the compounds tested, VUF8430 behaved as a
full agonist (a = 0.92 ± 0.02) in the GTPcS assay and
induced at 100 mg/kg subcutaneously (sc) a 92 % inhibi-
tion of paw edema; JNJ7777120, VUF10460 and
clobenpropit behaved as partial agonists (a = 0.42 ± 0.05,
0.13 ± 0.07 and 0.21 ± 0.02, respectively) and induced
77.02, 65.58 and 66.73 % inhibition of paw edema,
respectively. VUF10519 and VUF10497 were neutral
antagonists in the GTPcS assay (a = 0) and induced 38.18
and 32.36 % inhibition of paw edema, respectively, at 2 h.
In conclusion, present data suggest that the functional
activity of H4R ligands in rat assays in vivo does not
correlate with their functional behaviour in vitro. Surpris-
ingly, H4R agonists were more effective than H4R
antagonists as inhibitors of carrageenan-induced edema.
Department of Human Anatomy, Pharmacology and
Forensic Medicine, Section of Pharmacology, University of
Parma, 43125 Parma, Italy. E-mail: maristella.adami@
unipr.it
COMPARATIVE mRNA EXPRESSION PROFILING
IN NON-STIMULATED VERSUS H4R STIMULATED
HUMAN LYMPHOCYTES
S. Mommert, D. Pischke, O. Dittrich-Breiholz, M. Kracht,
H. Stark, R. Gutzmer, T. Werfel
The histamine H4 receptor (H4R) contributes to the regu-
lation of several major immune functions. In antigen
presenting cells, the down-regulation of pro-inflammatory
cytokines and chemokines has been observed. In contrast,
regarding human lymphocytes, in particular CD4 + T cells,
it has been shown that the H4R is up-regulated in Th2
polarized T cells and its activation leads to an increase in
the expression of the pro-inflammatory cytokine IL-31. In
human Th17 cells stimulation with either histamine or H4R
agonists enhances the production of IL-17.
In order to obtain a more comprehensive insight into the
cellular activities of human lymphocytes in response to
H4R stimulation, we performed microarray-based mRNA
expression profiling, using the Whole Human Genome
Oligo Microarray (G4845A, ID 026652, Agilent Technol-
ogies) which contained 44495 oligonucleotide probes
covering roughly 27390 human transcripts. For this pur-
pose we treated human Th2 polarized T cells, CD8 + T
cells and natural killer cells (NK cells) with the selective
H4R agonist ST-1006 and compared the mRNA expression
profiles with non stimulated control cells of the same
origin.
We detected 13 genes which were differentially regu-
lated in the Th2 cell group, 79 genes in the CD8 + T cell
group and 17 genes in the NK cell group. Interestingly,
gene expression profiling showed no overlap of genes
induced via H4R in these three different lymphocyte sub-
types. Regarding Th2 cells, H4R stimulation had no effects
on the expression of those cytokines, chemokines and
transcription factors which characterise the classical Th2
phenotype. For CD8 + T cells and NK cells microarray
analysis revealed the up-regulation of particular chemokine
receptors and chemokines.
Selected targets which were identified by this study will
be investigated more thoroughly by qRT-PCR and protein
analysis to further clarify the potential of targeting the H4R
for therapeutic benefit in a wide range of immune
disorders.
Division of Immunodermatology and Allergy Research,
Department of Dermatology and Allergy, Hannover Med-
ical School, Carl-Neuberg-Str.1, D-30625 Hannover,
Germany. E-mail: Mommert.Susanne@mh-hannover.de
BLOOD HISTAMINE LEVELS AND SKIN H4R
EXPRESSION IN PATIENTS WITH CHRONIC
SPONTAEOUS URTICARIA
M.P. Makris, N.L. Lethbridge, E. Zampeli, X.S. Aggelides,
P.L. Chazot, E. Tiligada
Chronic spontaneous urticaria (CU) is a common skin
disorder characterized by histamine (HA) release from
activated skin mast cells and basophils. An underlying
cause remains elusive and symptomatic therapies often
lack efficacy, thus urging the need for the identification of
more beneficial therapeutic strategies. Considering the
recent concept of the immunomodulatory role of the HA
H4 receptor (H4R), this study aimed to assess the rela-
tionship of blood HA levels and skin H4R expression to the
response of CU patients to standard therapy. Peripheral
blood samples were collected from adult male (n = 3) and
female (n = 10) CU patients of 45 ± 12 years of age,
unresponsive to anti-H1R drugs (group A) and with full
remission of urticarial lesions during anti-H1R treatment
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(group B). Whole blood and serum HA levels were deter-
mined fluorometrically and presented as ng/ml of blood.
H4R expression was detected immunohistochemically on
puncture biopsies (4 mm) from the urticarial lesions.
Whole blood HA levels were significantly higher
(p \ 0.01) in patients with refractory CU (30.7 ± 12.3,
n = 9) compared to responsive subjects (13.3 ± 2.3,
n = 4). In contrast, serum HA levels were comparable in
the two groups, being 7.7 ± 0.8 and 9.1 ± 1.3 for group A
and B, respectively. Interestingly, a significant correlation
(r \ 0.05) between whole blood HA levels and monocyte
counts was observed in group A samples. Prominent anti-
hH4R immunoreactivity was detected in the skin biopsies,
with no apparent change in total skin sample extracts.
However, representative samples from the two groups
showed differential anti-hH4R expression profiles. These
data provide the first evidence linking whole blood HA
levels and monocyte counts in refractory CU. The differ-
ential H4R expression profile in skin biopsies from
responsive and unresponsive patients points to a probable
role of the H4R in CU that deserves further consideration.
This work was part of FP7 EU COST Action BM0806
Allergy Unit Attikon Hospital, University of Athens
Medical School, 12462 Athens, Greece. E-mail: aityliga@
med.uoa.gr
LIGAND-DIRECTED H4R SIGNALLING: A STEP
FORWARD TO OPTIMIZED H4R DRUGS?
S. Nijmeijer, E.M. Rosethorne, H.F. Vischer, S.J. Charlton,
R. Leurs
G protein-coupled receptors (GPCRs) acquired their name
from the ability to activate G proteins to induce intracel-
lular signalling. However, not only G proteins transduce
GPCR activation, also other proteins such as b-arrestins
can function as signalling scaffolds. Moreover, GPCR
ligands do not always activate G protein- and b-arrestin-
mediated signalling to an equal amount. This phenomenon
is known as ligand-directed signalling and has been
observed for various GPCRs.
The histamine H4R was previously shown to couple to
Gai proteins, but has recently been added to the list of
GPCRs that display ligand-directed signalling. The well-
known antagonist JNJ 7777120 was surprisingly identified
as a partial agonist in a PTX-insensitive PathHunter b-
arrestin recruitment assay. In addition, JNJ 7777120
induced ERK phosphorylation in a time frame typical for
b-arrestin-mediated signalling.
These observations led us to re-evaluate a variety of
H4R compound classes and to investigate their ability to
induce PTX-sensitive CRE activity versus PTX-insensitive
b-arrestin recruitment. We have identified compounds with
a strong bias towards one of the tested pathways. The
newly identified biased H4R compounds will be useful
pharmacological tools to study the functional consequences
of biased H4R signalling in future research.
VU University Amsterdam, De Boelelaan 1083, 1081HV
Amsterdam, The Netherlands. E-mail: r.leurs@vu.nl
DIFFERENTIAL BINDING KINETICS
OF HISTAMINE H4 RECEPTOR LIGANDS:
FROM QUICK LEAVERS TO LONG-STAY
BINDERS
H.D. Lim, S. Nijmeijer, H.F. Vischer, C. de Graaf,
R.A. Smits, I.J.P. de Esch, R. Leurs
The histamine H4 receptor is a G protein-coupled receptor
associated with various inflammatory diseases such as
allergic asthma, rheumatoid arthritis and pruritus. For this
reason, H4 receptor antagonists currently receive consid-
erable attention as potential therapeutics. In our search for
new H4 ligands, several low affinity fragments were opti-
mized to new high affinity H4 receptor antagonists.
Interestingly, study of the binding kinetics at the human H4
receptor showed very different dissociative half-lives for
several compounds. This could potentially explain part of
the in vivo effectiveness of e.g. the reference antagonist
JNJ 7777120. In conclusion, this study of H4 ligands
indicates important differences in H4 receptor binding
kinetics, which could ultimately be responsible for differ-
ences in in vivo activities.
VU University Amsterdam, De Boelelaan 1083, 1081HV
Amsterdam, The Netherlands. E-mail: r.leurs@vu.nl
DERIVATIVES OF 2-AMINO-1,3,5-TRIAZINE
AS NEW HISTAMINE H4 RECEPTOR LIGANDS
K. Kamińska, M. Więcek, T. Kottke, S. Schwed, R. Seifert,
H. Stark, J. Handzlik, K. Kieć-Kononowicz
Histamine—the biogenic monoamine—fulfills important
physiological functions through four histamine receptor
subtypes (H1-H4). The youngest member of this receptor
family is the H4 receptor (H4R) which was discovered at
the turn of 2000 and 2001 year independently by several
research groups. Because of H4R expression mainly in cells
and tissues of immune system (monocytes, mast cells,
dendritic cells, eosinophils, basophils, T-leukocytes) its
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role in inflammatory and (auto)immunological processes
and disorders was suggested. Positive effects were
observed in treatment of animal models of some diseases
(e.g. allergic rhinitis, asthma, pruritus or pain) in the
presence of H4R antagonists/inverse agonists.
Extending our SAR investigation in the group of 1,3,5-
triazine derivatives—based on previous results and litera-
ture data we searched for new potent and selective H4R
ligands in the group of (4-methylpiperazin-1-yl)-1,3,5-
triazin-2-amines by changing aryl substituent in 6-position
to heteroaryl ring system, e.g. (un)substituted thiophene,
benzothiophene, pyridine or imidazopyridine.
The compounds were obtained by the direct reaction of
appropriate carboxylic esters with guanidine derivative. In
silico predictions of toxicity and drug-likeness by newly
obtained compounds were also carried out. Compounds
were evaluated for their affinity at H4R with radioligand
binding assays on transiently expressing recombinant
human H4R in the Sf9 insect cells using [
3H] histamine as
radioligand.
As one of the most promising substitution pattern the
thienyl derivatives were characterized with significant
affinity to H4 receptor, e.g. 4-(3-chlorothienyl-2-yl)-6-(4-
methylpiperazin-1-yl)-1,3,5-triazin-2-amine showed a Ki
value of 137 nM.
Kindly supported by the Polish Ministry of Science and
Higher Education Grants No: 594/N-COST/2009/0 and by
the FP7 EU COST Action BM0806.
Department of Technology and Biotechnology of Drugs,
Jagiellonian University Medical College, Medyczna 9, 30-
688 Kraków, Poland. E-mail: kate.anna.kaminska@gmail.
com
MICROSATELLITE REPEAT EXPANSIONS
IN HUMAN HISTAMINE4 RECEPTOR GENE
S. Micallef, E. Quinn, D. Morris, A. Sasse
Microsatellite repeat expansions have been implicated in a
number of neurological disorders in humans, e.g., Fragile X
syndrome, Huntington’s disease and Kennedy’s disease.
Both loss-of-function and gain-of-function mechanisms are
recognised from expanded trinucleotide repeats, and such
microsatellites can be located in both coding and non-
coding regions of the gene. This study targets genetic
polymorphism in the promoter region of the human hista-
mine4 receptor (hH4R), which contains variable number of
tandem repeat polymorphisms (VNTR). This VNTR is a
CAA triplet repeat expansion and ranges from 10 to 19
repeats (10R and 19R, respectively). In preliminary
unpublished data it was indicated that the trinucleotide
repeats 10R, 13R, 14R and 15R, are more common in
schizophrenia patients. The aim of this study was to
investigate the association of this genetic variation to
schizophrenia and to assess promoter activity resulting
from this polymorphism. Linkage disequilibrium (LD)
analysis was carried out on HapMap samples between the
VNTR in the promoter region and known Single Nucleo-
tide Polymorphisms (SNPs) at this locus. The SNPs at
hH4R were tested for association with schizophrenia as part
of genome wide association studies (GWAS) conducted by
the International Schizophrenia Consortium (ISC). Geno-
typing showed that the 13R allele is in high LD with
rs17797945, while the 10 microsatellite is in high LD with
rs628764 and rs615283. The SNP rs17797945 is weakly
associated with schizophrenia in the ISC GWAS (P
0.007876). The promoter region including the variations in
VNTR have been cloned and are currently being subcloned
in a pGL3 promoter-less vector for assessment of promoter
activity. This assay will indicate the functional impact
which this length polymorphism has on gene expression.
The research work disclosed in this publication is fun-
ded by a STEPS Fellowship (Malta). Supported by
European COST Action BM0806 ‘Recent Advances in
Histamine Receptor H4R Research’.
Trinity College Institute of Neuroscience and School of
Pharmacy and Pharmaceutical Sciences, Trinity College
Dublin, Ireland. E-mail: sassea@tcd.i.e
SILENCING HUMAN H4R GENE BY NOVEL
TRIPLEX-FORMING MOLECULE
M. Falah, M. Azab, S. Shdafnay, A. Michaeli, A. Rayan
Over the past two decades, there has been considerable
interest in developing novel chemicals that can specifically
silence a gene and inhibit its expression. Any approach that
can specifically and efficiently suppress the expression of
genes is recognized to be highly valuable. Two approaches
that have received much attention are antisense oligonu-
cleotides and siRNA. Both approaches target the RNA
product of the expressed gene and in due course result in
destruction of this target. An alternative approach that
directly targets and inhibits gene expression utilizes tri-
plex-forming molecules (TFMs). One advantage of this
strategy is the relatively few DNA molecules that need to
be targeted (usually 1 or 2 per cell), allowing for dosage
reductions that lower toxicity for patients. This provides a
distinct advantage over targeting RNA molecules, which
are continuously produced when the gene is transcribed,
requiring the antisense oligonucleotide or siRNA to be
constantly present in the cell. Targeting DNA directly also
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prevents biofeedback loops from becoming effective drug
resistance mechanisms.
Based on our proprietary bioinformatics tools, we have
designed a highly specific molecule that tightly binds a
selected DNA sequence along the hH4R gene, stopping its
RNA transcription. This novel synthetic molecule which
targets the hH4R gene (hH4R-TFM) is highly selective and
designed not to interact with non-targeted sequences along
the human genome. Our TFMs are chemically engineered to
bind to the major groove of the targeted DNA fragment. Our
molecules interact with the major groove by forming a
stable Hoogsteen interaction. This mode of binding is sig-
nificantly different from those of antisense oligonucleotides
or siRNAs which bind nucleic acids via base-pairing.
The H4R-TFM developed bound efficiently with its DNA
target at physiological temperature and pH, prevented ampli-
fication in RT-PCR and, therefore, can now be potentially used
to disrupt in vitro transcription and prevent replication of DNA
containing a binding site for the hH4R-TFM.
Al-Qasemi Academic College, Baka El-Garbiah 30100,
Israel. a_rayan@qsm.ac.il.
THE HISTAMINE H4 RECEPTOR
IS OVEREXPRESSED IN THE KIDNEY
OF DIABETIC RATS
A.C. Rosa, C. Grange, M.A Katebe, E. Benetti, M. Collino,
G. Miglio, G. Camussi, P.L. Chazot, R. Fantozzi
Histamine is known to be synthesized in the glomeruli, to
increase second messenger levels in isolated glomeruli and
to influence renal hemodynamics, including microcircula-
tion. Previous studies demonstrated the glomerular
expression of histamine H1 receptors (H1R) and H2R, while
the most recently discovered H3R and H4R were poorly
investigated. The aim of this study was to evaluate the H4R
expression in the rat kidney. As renal histamine concen-
tration was found to be significantly increased in
streptozotocin (STZ)-treated rats, a further aim was to
evaluate whether the kidney H4R density varies in diabetic
rats. Insulinopenic diabetes was induced in 12 out of 24
8-week-old male Wistar rats by a single i.v. injection of
STZ, and animals were sacrificed 6 weeks later. Serum and
urinary evaluation was performed to assess glycaemia,
creatinine clearance and proteinuria. The kidneys were
collected and processed for PCR or immunohistochemistry
analyses. Diabetic rats (glycaemia [300 mg/dl) had a
higher creatinine clearance and proteinuria than nondia-
betic animals. The H4R mRNA expression in control rats
was at a very low level. Consistently, H4R was undetect-
able by immunohistochemistry using a well validated anti-
H4R antibody. In contrast, in diabetic rats H4R was pro-
foundly upregulated.
Immunohistochemistry experiments revealed a higher
immune-positivity in the cortex and medulla in comparison to
the papilla. To ascertain the cellular localization of H4R,
colocalization experiments were performed. When H4R
immunostaining was compared to that of Tamm-Horsfall gly-
coprotein, a close overlap in expression topology was observed.
In conclusion, our results indicated that H4R is expres-
sed in the kidney of healthy rats, although at a very low
level, and it is upregulated in diabetic male rats. This
receptor is expressed by resident renal cells of the thick
ascending limb of the loop of Henlé, thus suggesting a
possible role in modulating the transmembrane soluble
transport processes.
Funded by Royal College of Anaesthesia/BJA and
COST Action BM0806; Dr Rosa performed a successful
STSM in the laboratory of Dr Chazot (UK)
Dipartimento di Scienza e Tecnologia del Farmaco,
Torino, Italy. E-mail: ariannacarolina.rosa@unito.it
THERAPEUTIC POTENTIAL OF H4R AGONISTS
IN AN EXPERIMENTAL MODEL OF HUMAN
BREAST CANCER
D. Martinel Lamas, M. Croci, L. Sambuco, E. Carabajal,
N. Massari, R.M. Bergoc, E.S. Rivera, V.A. Medina
We have previously reported the presence of the histamine H4
receptor (H4R) in benign and malignant lesions and cell lines
derived from the human mammary gland. The H4R is one of
the main subtypes responsible for the histamine-induced
responses in MDA-MB-231 breast cancer cells. The aim of the
present work was to evaluate the effects of H4R ligands on the
survival, tumour growth rate, metastatic capacity and
molecular pattern of expression of antigens related with the
proliferative and apoptotic potential in a breast cancer
experimental model. For that purpose, we established xeno-
grafted tumours of the highly invasive human breast cancer
cell line MDA-MB-231 in immune deficient nude mice. We
employed the following H4R agonists: histamine (1 and 5 mg/
Kg, sc), clozapine (1 mg/Kg, sc), and the experimental com-
pound JNJ28610244 (10 mg/Kg, sc).
Results indicate that developed tumours were highly
undifferentiated and that the H4R was the major hista-
mine receptor expressed. They also exhibited high
levels of histidine decarboxylase, histamine content and
proliferation marker (PCNA) while displaying low levels
of apoptosis. Mice of the untreated group displayed a
median survival of 60 days, and a tumour doubling time
exponential growth of 7.4 ± 0.6 days. A significant
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decrease in tumour growth evidenced by an augmentation
of the tumour doubling time was observed in H4R agonist
groups (13.1 ± 1.2, P \ 0.01 in histamine group;
15.1 ± 1.1, P \ 0.001 in clozapine group; 10.8 ± 0.7,
P \ 0.01 in JNJ28610244 group). The effect was associ-
ated with a decrease in the expression levels of the H4R
(32.8 vs. 6.6 % and 3.0 in clozapine and JNJ28610244
groups, respectively, P \ 0.05) and of the PCNA (83.1 vs.
63.2 %, 64.2, 70.5 % in histamine, clozapine and
JNJ28610244 groups, respectively, P \ 0.05). Histamine
treatment significantly increased median survival (78 days;
***P \ 0.0005, Log rank test and Gehan-Breslow-Wilco-
xon test). We conclude that histamine through the H4R
exhibits a crucial role in tumour progression. Therefore,
H4R ligands offer novel therapeutic potential as adjuvants
for breast cancer treatment.
We thank Dr. Nicholas Carruthers from Johnson &
Johnson Pharmaceutical Research & Development for the
JNJ28610244 compound.
Laboratorio de Radioisótopos, Facultad de Farmacia y
Bioquı́mica, Universidad de Buenos Aires, 1113, Buenos
Aires, Argentina. E-mail: vmedina@ffyb.uba.ar
ESTABLISHMENT OF A HISTAMINE METHODS
AND TOOLS DATABASE
H.G. Schwelberger
COST Action BM0806 Recent Advances in Histamine
Receptor H4R Research brings together scientist and
industrial partners from many different disciplines, who
provide enormous expertise in their respective field. In
order to make this expertise transparent and usable for all
action members and for histamine researchers in general,
one goal of Working Group 1 is to establish and run an
internet database covering all methods and tools available
at participating institutions.
In the first phase to build this database, a simple ques-
tionnaire was used to collect, evaluate and combine
information on available methods and tools from individual
participants. This methods and tools overview will serve as
a contents and reference point for users. In the second
phase, detailed protocols and descriptions of tools are
collected from individual contributors and made available
for users in a common, easy to use format. In the third
phase, the database will be constantly updated with new
information and errors will be corrected based on user
feedback.
In its final version, this histamine methods and tools
database should provide a comprehensive collection of all
available methods (techniques, assay systems, cell systems,
animal models, patient based studies), include ready-to-use
protocols, give contact information for method based
inquiries (technical help), inform about source of critical
tools (antibodies, reagents, compounds), and finally iden-
tify areas where new methods, techniques or tools should
be developed.
This work was supported by COST Action BM0806.
Medical University Innsbruck, Department of Visceral,
Transplant and Thoracic Surgery, Molecular Biology
Laboratory, Schöpfstrasse 41, A-6020 Innsbruck, Austria.
E-mail: hubert.schwelberger@i-med.ac.at
S54 The European Histamine Research Society
123
Neurological aspects of histamine
The European Histamine Research Society S55
123
S56 The European Histamine Research Society
123
UNDERSTANDING HOW HISTAMINE INDUCES
NEURON DIFFERENTIATION
G. Rodrı́guez, I. Velasco, G. Garcı́a-López,
H. Flores-Herrera, N.F. Dı́az, A. Molina-Hernández
Histamine is a neurotransmitter in the central nervous
system. This amine is one of the first neurotransmitters to
appear during development and it reaches its maximum
concentration at the same time as neuron differentiation
peak. This suggests that histamine has an important role
in neurogenesis. We have previously shown that hista-
mine is able to increase neuronal differentiation of neural
stem cells in vitro, by activating the histamine H1
receptor. In this study, we start to explore the mechanism
involved in neuronal differentiation stimulated by hista-
mine. We used rat neural stem/progenitor cells from
embryonic day 14 in passage two. We performed two
protocols of histamine treatments; one when it was
present during both cell proliferation and differentiation
and the other where histamine was only present during
cell differentiation.
Immunocytochemistries were performed to evaluate
cell division and neuron differentiation. RT-PCR or qRT-
PCR were used to explore the expression of some
important transcriptional factors involved on cell com-
mitment. Results indicate that histamine is required
during cell proliferation in order to increase neuron dif-
ferentiation, probably by increasing neuron commitment,
since histamine is able to increase asymmetric cell divi-
sion during the proliferative phase as well as the
expression of FGF-receptor type 1, Neurogenina 1 and
Prospero 1 expression. We proposed that the increase on
deep layer cortical neurones, measured by an increase on
FOXP2-positive cells, due to histamine is related to:
(a) an increase on asymmetric cell division and (b) an
increase on FGF-receptor 1, Prospero 1 and Neurogenin
1 expression. These effects might be related to the acti-
vation of histamine H1 receptor, since the presence of
chlorpheniramine prevented the increase on FGF-receptor
1 expression.
Departamento de Biologı́a Celular. Instituto Nacional
de Perinatologı́a ‘‘Isidro Espinosa de los Reyes’’, Torre de
Investigación. Montes Urales 800, Delegación Miguel
Hidalgo. Colonia Lomas de Virreyes, CP 11000. México
City, Mexico. E-mail: anayansimolina@gmail.com.mx
INHIBITION OF DEPOLARIZATION-EVOKED
[3H]-DOPAMINE RELEASE BY THE ACTIVATION
OF THE HUMAN HISTAMINE H3 RECEPTORS
OF 445 AND 365 AMINO ACIDS EXPRESSED
IN HUMAN NEUROBLASTOMA SH-SY5Y CELLS
G. Nieto-Alamilla, J. Escamilla-Sánchez,
R. González-Pantoja, J.-A. Arias-Montaño
The histamine H3 receptor (H3R) is mainly located on
nerve terminals and controls release of histamine and other
transmitters, including dopamine. The alternative splicing
of the human H3R gene produces several receptor isoforms,
of which variants of 365 and 445 amino acids (hH3R365 and
hH3R445) are expressed in brain. The aim of this work was
to determine, by using a cellular model, whether these two
isoforms regulate in a different manner neurotransmitter
release.
Two sub-lines of human neuroblastoma SH-SY5Y cells
stably expressing either isoform (hH3R365 or hH3R445)
were generated with expression levels of 583 ± 151 and
805 ± 175 fmol/mg protein and Kd values for [3H]-N-
methyl-histamine of 0.90 ± 0.13 and 0.86 ± 0.12 nM,
respectively. There were no significant differences in the
affinities of both isoforms for the H3R ligands histamine
(pKi values 8.50 ± 0.10 and 8.55 ± 0.07), R-a-methyl-
histamine (RAMH, 9.45 ± 0.06 and 9.63 ± 0.06) or
clobenpropit (8.70 ± 0.09 and 8.95 ± 0.12).
The H3R agonist RAMH was more efficacious to
inhibit forskolin-induced cAMP accumulation in the SH-
SY5Y-hH3R445 cell line (-70.6 ± 5.2 % vs. -38.4 ± 5.4
% for the SH-SY5Y-hH3R365 cells), without significant
difference in the pIC50 estimates (8.77 ± 0.17 vs. 8.42 ±
0.14).
Neurotransmitter release was assayed in cells differenti-
ated by treatment for 7 days with 12-O-tetradecanoyl-
phorbol-13-acetate, TPA (20 nM), and retinoic acid
(10 lM). The release of [3H]-dopamine induced by depo-
larization with high K+ (100 mM) was significantly reduced
by RAMH (100 nM), but the effect was significantly larger in
the SH-SY5Y-hH3R445 cell line (-30.9 ± 4.2 %) than in the
cells expressing the hH3R365 isoform (-15.1 ± 4.8 %).
Our results indicate that in accord with previous data for
other signaling pathways, the hH3R445 isoform is more
efficacious in inhibiting depolarization-evoked neuro-
transmitter release.
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Supported by Cinvestav y Conacyt (grant 128205 to
J.A.A.M.)Centro de Investigación y de Estudios Avanzados
(Cinvestav) del IPN, Zacatenco, 07360 México, DF, Méx-
ico. E-mail: gustavonietoalamilla@gmail.com
DYNAMIC REGULATION OF HISTAMINERGIC
AND DOPAMINERGIC NETWORKS
IN ZEBRAFISH BRAIN
P. Panula, M. Sundvik, S. Semenova, Y.-C. Chen
Histamine regulates motor functions through interactions with
the dopaminergic system via at least striatal and nigral
mechanisms. In Parkinson’s disease (PD), histamine levels are
increased selectively in the striatum and substantia nigra.
However, it has been unclear if this is due to the PD process,
treatment with L-DOPA and other drugs, or if it is an impor-
tant factor in disease pathogenesis. Histamine is also
important in Tourette syndrome, where hdc mutation is linked
to the disease and H1 receptor pathway changes are found. We
have established methods to study detailed changes in mod-
ulatory transmitters in zebrafish, a species in which one can
count all neurons with specific markers. Translation inhibition
of tyrosine hydroxylase 1 (TH1) caused a locomotor abnor-
mality, decline in dopamine, noradrenaline and adrenaline
levels. Translation inhibition of tyrosine hydroxylase 2 (TH2),
which is expressed in the close vicinity of the histaminergic
neurons, caused a decline in dopamine levels and an increase
in hdc mRNA and number of histaminergic (hdc mRNA
expressing and histamine immunoreactive) neurons. In
agreement with a concept of bidirectional regulation of the
histamine system by dopaminergic input, L-DOPA and
dopamine receptor agonists downregulated the number of
histaminergic neurons. The results suggest that L-DOPA or
dopamine produced by TH2 neurons exerts trophic effects on
histaminergic neurons in the brain.
Neuroscience Center and Institute of Biomedicine,
University of Helsinki, POB 63, 00014, Finland. E-mail:
pertti.panula@helsinki.fi
HUMAN ASTROCYTES TRANSPORT HISTAMINE
THROUGH PLASMA MEMBRANE MONOAMINE
TRANSPORTER
T. Yoshikawa, F. Naganuma, T. Nakamura, T. Iida,
R. Harada, A. Mohsen, K. Yanai
The removal of extracellular histamine from the synaptic
cleft is an essential process for terminating the signal
transduction. Previous studies, using rodents, revealed that
histamine was mainly transported and metabolized in
astrocytes. However, the histamine transport activity of
human astrocytes and the mechanism of histamine uptake
remained to be elucidated.
We first examined histamine uptake in normal human
astrocytes using [3H]-histamine. Histamine was taken up
into the cells in a time- and dose-dependent manner. The
values of Km and Vmax were high and the uptake was not
dependent on the extracellular concentration of Na+/Cl-,
suggesting that a low-affinity/high-capacity and Na+/Cl-—
independent transporter(s) are responsible for histamine
transport in human astrocytes. Histamine is reported to be a
substrate for three low-affinity/high-capacity and Na+/Cl--
independent transporters: organic cation transporter 2
(OCT2), OCT3 and plasma membrane monoamine trans-
porter (PMAT). The inhibition assays using various
reagents indicated OCT2 was not involved in the histamine
transport, because tetraethylammonium, a substrate for
OCT2, did not inhibit histamine transport in human astro-
cytes. RT-PCR analysis revealed that PMAT was most
highly expressed in human astrocytes, and OCT2 and OCT3
were barely detected. Also, PMAT knockdown using siR-
NA resulted in a remarkable reduction of histamine uptake
with a corresponding decrease in PMAT expression.
In the present study, we clearly demonstrated that
human astrocytes had sufficient ability for histamine
transport and that PMAT played a predominant role in
histamine transport by human astrocytes. These findings
indicate that histamine transport through PMAT in human
astrocytes is involved in the regulation of extraneuronal
histamine concentration and the activity of histaminergic
neurons.
Tohoku University Graduate School of Medicine,
Department of Pharmacology, Sendai, 980-8575, JAPAN.
E-mail: yanai@med.tohoku.ac.jp
DISCOVERY OF NOVEL H1R AND H3R
MODULATORS THROUGH A MULTIPLEXED
SCREENING STRATEGY UTILIZING SMALL
MOLECULES FROM A CNS DOS FOCUSED
LIBRARY
E. Holson, J.T. Lowe, S. Kesavan, L.A. Marcaurelle,
J. Beaudouin, E. Comer, E. Davoine, K. Dennehy,
J.R. Duvall, T. Hanania, M.D. Lee IV, M. Lewis, D. Lowe,
J.-C. Marie, C.A. Mulrooney, G. Muncipinto, T. Petryshen,
B.-C. Suh, F. Wagner, J. Wei, M.A. Foley
In an effort to synthesize a diverse library of unique
compounds biased for CNS drug like properties we utilized
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in silico, in vitro, cellular and in vivo models to inform
library design. An azetidine based core provided a versatile
common intermediate en route to a variety of fused,
bridged and sprirocyclic ring systems. A phenylethylamine
structural motif embedded within the core scaffold pro-
vides a pharmacophoric element common to a number of
hormones, neurotransmitters, drugs and natural products
known to affect the central nervous system. Utilizing an
unbiased and multiplexed screening strategy on represen-
tative scaffolds we discovered novel, relatively potent and
highly selective compounds which modulate the H1 and
H3 receptors in vitro and in vivo. These compounds act as
H3 antagonists/inverse agonists and functionally selective
H1 agonists and display antidepressant and cognitive
enhancing effects in mice. Recent genetic findings impli-
cating histaminergic pathways in the etiology of Tourette
syndrome and possible overlap with autism, OCD and
ADHD offer intriguing opportunities for therapeutic
intervention.
The Broad Institute of MIT and Harvard, 7 Cambridge
Center, Cambridge, MA 0246, USA. E-mail: edholson@
broadinstitute.org
HISTAMINE PROMOTES NEURONAL
DIFFERENTIATION OF CULTURED MIDBRAIN
NEURAL PRECURSOR CELLS BUT REDUCES
DOPAMINE NEURONAL NUMBERS IN VITRO
AND IN VIVO
I. Escobedo, A. Molina-Hernández and I. Velasco
During embryonic development, histamine (HA) is one of
the first neurotransmitters to appear in the central nervous
system (CNS). Particularly, in the region of rat ventral
midbrain (VM), HA increases its concentration fivefold at
embryonic day 14–16 and then it decreases until birth,
reaching the low concentrations that are present in the
adult brain. Neuronal differentiation in the VM correlates
temporally with the increase in the concentration of HA
in this region. The role of HA during brain development
is unknown. In this work, we studied the correlation
between HA increases with the process of neurogenesis
on rat VM in vitro and in vivo. The effect of increasing
HA concentrations (from 100 nM to 1 mM) during pro-
liferation, differentiation and cell death of VM neural
precursor cells (NPC) in vitro were analyzed. We found
that VM cultures express HA receptors, and that 10 lM
HA significantly increased neuronal differentiation from
21 to 37 %. Pharmacological assays showed that the
effect of HA on neuronal differentiation is mainly due to
activation of H2 receptors. We found that almost every
HA concentration used increased twofold apoptotic cell
death compared to control condition, evaluated by TUN-
EL assay. Also the proportion of dopaminergic neurons
was significantly decreased after 1 mM HA treatment of
cultured VM NPC. All experiments were performed by
triplicate. We also evaluated the role of HA in vivo
through intrauterine injections on the developing brain of
Wistar pregnant rats. We found that HA administration
decreased the number of dopaminergic neurons in the
VM. This is consistent with the in vitro data. Results are
representative of a cohort of 5 experimental animals.
Thus, these results imply that HA might be acting as a
transient developmental signal that modulates neurogen-
esis and dopamine neuron differentiation/survival in the
rat midbrain.
Instituto de Fisiologı́a Celular-Neurociencias, Univers-
idad Nacional Autónoma de México, DF 04510, México.
E-mail: iescobed@email.ifc.unam.mx
THE HISTAMINE H3 RECEPTOR ANTAGONIST
A-960656 IS EFFECTIVE IN ANIMAL MODELS
OF OSTEOARTHRITIS AND NEUROPATHIC PAIN
G.C. Hsieh, M.D. Cowart, L. Black, C. Zhan, E.J. Gomez,
M. Pai, M.I. Strakhova, A.M. Manelli, T.L. Carr,
T.R. Garrison, J.D. Brioni
Histamine H3 receptor antagonists have been widely
reported to improve performance in preclinical models of
cognition and efficacy in pain models has recently been
described. A-960656 was profiled as a new structural
chemotype. A-960656 was potent in vitro in histamine H3
receptor binding assays (rat Ki = 76 nM, human Ki = 21
nM), exhibited functional antagonism in blocking agonist-
induced [35S]GTPcS binding (rat H3 Kb = 107 nM,
human H3 Kb = 22 nM), and was highly specific for H3
receptors in broad screens for non-H3 sites. In a spinal
nerve ligation model of neuropathic pain, oral doses of 1
and 3 mg/kg were effective 1 h post dosing with an ED50
of 2.1 mg/kg and a blood EC50 of 639 ng/ml. In a model
of osteoarthritis pain, oral doses of 0.1, 0.3, and 1 mg/kg
were effective 1 h post dosing with an ED50 of 0.52 mg/
kg and a blood EC50 of 233 ng/ml. The antinociceptive
effect of A-960656 in both pain models was maintained
after sub-chronic dosing up to 12 days. All studies used
male Sprague–Dawley rats weighing 250–300 g at the
time of testing. A-960656 had excellent rat pharmacoki-
netics (t1/2 = 1.9 h, 84 % oral bioavailability) with rapid
and efficient brain penetration, and was well tolerated in
CNS behavioural safety screens. A-960656 has properties
well suited to probe the pharmacology of histamine H3
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receptors in pain. Its potency and efficacy in animal pain
models provides support to the notion that histamine H3
receptor antagonists can effectively attenuate nociceptive
processes.
Neuroscience Research, Abbott Laboratories, Abbott
Park, IL 60064, USA. E-mail: gin.c.hsieh@abbott.com
THE HISTAMINE H4 RECEPTOR IS EXPRESSED
ON BOTH PEPTIDERGIC C- and Ad SENSORY
FIBRES AT THE LEVEL OF THE RAT SKIN,
DORSAL ROOT GANGLION AND DORSAL HORN
OF THE SPINAL CORD
M. Katebe, P.L. Chazot
The histamine H4 receptor (H4R) is the most recent
receptor identified belonging to the histamine receptor
subfamily of G-protein coupled receptors (GPCR). Until
recently the H4 receptor was thought to be largely
expressed on haematopoietic cells and as a result, is a
possible key new target for inflammatory disorders.
Immunohistochemical studies from our laboratory and
others have revealed strong H4R expression on the soma
of cervical and lumbar dorsal horn sensory neurons with
more intense staining on small and medium diameter
cells, and subpopulations of dorsal root ganglia (DRG),
suggesting a potential role in nociception and a new target
for the modulation of chronic inflammatory pain disor-
ders. The H4R ligand, JNJ7777120, exhibits profound
antipruritic and analgesic effects in the Freund’s Com-
plete Adjuvant (FCA) chronic pain model, the latter
where spinal NMDARs are hyperactivated (unpublished
data). Our hypothesis was that the H4R would be
expressed on C-fibres.
We have used a double immunofluoresence labelling
approach to determine the possible co-localisation of
H4Rs on peptidergic C-(Substance P) and Ad (CGRP)
nociceptive fibres at the level of skin, DRG and the
dorsal horn neurones of the spinal cord in the rat. At all
levels of the sensory pain pathway tested, our results
surprisingly show expression on both peptidergic C-fibres
and on Ad fibres, the latter particularly prominent at the
level of the DRG and the skin. This expression profile
contrasts with the H3R, which was found to be expressed
only on a subset of Ad fibres, and is undetectable on
C-fibres.
School of Biological and Biomedical Sciences, Durham
University, DH1 3LE. Durham, UK. E-mail: m.a.katebe@
durham.ac.uk
H1R SIGNALING IN ANTIGEN PRESENTING
CELLS IS DISPENSABLE FOR ELICITING
PATHOGENIC T CELLS IN EXPERIMENTAL
ALLERGIC ENCEPHALOMYELITIS
N. Saligrama, R. Noubade, L.K. Case, M.E. Poynter,
C. Teuscher
The histamine H1 receptor (Hrh1/H1R) was identified as a
shared autoimmune disease (SAID) gene in experimental
allergic encephalomyelitis (EAE) and autoimmune orchitis,
the principal AI models of multiple sclerosis (MS) and
idiopathic male infertility, respectively. As a SAID gene,
Hrh1/H1R can exert effects in multiple cell types, including
endothelial cells, T cells, and antigen presenting cells at
critical check points during both the induction and effector
phases of disease. In this regard, we showed that selective
re-expression of histamine H1R by endothelial cells in
Hrh1-KO (H1RKO) mice significantly reduced disease
severity whereas histamine H1R expression by H1RKO T
cells complemented EAE severity and cytokine responses.
Given that the histamine H1R has been reported to influence
innate immune cell maturation, differentiation, chemotaxis,
and cytokine production, which in turn influences CD4+ T
cell effector responses, we selectively re-expressed H1R in
CD11b+ myeloid cells of H1RKO mice to test the hypoth-
esis that H1R signaling in these cells contributes to EAE
susceptibility and/or T cell effector responses. We have
demonstrated that transgenic re-expression of H1R by
H1RKO-CD11b
+ cells neither complements EAE suscepti-
bility nor T cell cytokine responses. These results further
highlight the cell-specific effects that an AID gene can play
in the pathogenesis of complex diseases such as EAE and
MS, and the need for cell-specific targeting in optimizing
therapeutic interventions based on such genes.
Department of Medicine and Pathology, University of
Vermont, Burlington, VT 05405, USA. E-mail: c.teuscher@
uvm.edu
EVIDENCE SUPPORTING THE EXISTENCE
OF A NOVEL HISTAMINERGIC PATHWAY
IN THE REGULATION OF EXPERIMENTAL
ALLERGIC ENCEPHALOMYELITIS
SUSCEPTIBILITY
N. Saligrama, L.K. Case, R. Del Rio, R. Noubade,
C. Teuscher
Histamine (HA) is a key regulator of experimental aller-
gic encephalomyelitis (EAE), the autoimmune disease
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model of multiple sclerosis (MS). Histidine decarboxylase
deficient mice (HDCKO), which are unable to synthe-
size HA, exhibit more severe EAE and increased IFN-c
production by splenocytes in response to myelin oligo-
dendrocyte glycoprotein 35–55. HA exerts its effects
through four different G protein coupled receptors
(GPCR): H1, H2, H3 and H4 (H1-4R). Each HA-receptor
has been shown to influence EAE pathogenesis. In the
mammalian brain, however, there is also evidence for the
existence of non-GPCR signaling by HA, which is pic-
rotoxin-sensitive and mediated by a chloride conductance.
In addition, c-aminobutyric acid (GABAA) receptor sub-
units can form HA-gated chloride channels in vitro
suggesting that an ionotropic HA-receptor might contain
known ligand-gated chloride channel subunits. To test the
hypothesis that non-GPCR signaling by HA plays a role
in the autoimmune responses that lead to EAE, we gen-
erated H1-4RKO mice and studied their susceptibility to
EAE. Here we report that in contrast to HDCKO mice,
H1-4RKO mice develop less severe EAE compared to
wild-type animals. Furthermore, splenocytes from immu-
nized H1-4RKO mice produce significantly less IFN-c
compared to WT mice. Taken together these data support
the existence of a novel HA signaling pathway in regu-
lating EAE susceptibility.
Department of Medicine and Pathology, University of
Vermont, Burlington, VT 05405, USA. E-mail; c.teuscher@
uvm.edu
COMBINATORIAL ROLES FOR HISTAMINE H1-H2
AND H3-H4 RECEPTORS IN AUTOIMMUNE
INFLAMMATORY DISEASE OF THE CENTRAL
NERVOUS SYSTEM
N. Saligrama, R. Noubade, L.K. Case, R. Del Rio,
and C. Teuscher
Multiple sclerosis (MS) is a chronic inflammatory demy-
elinating disease of the central nervous system in which
histamine (HA) and its receptors have been implicated in
disease pathogenesis. HA exerts its effects through four
different G protein-coupled receptors designated H1-H4.
We previously examined the effects of traditional single
HA receptor (HR) knockouts (KO) in EAE, the autoim-
mune model of MS. Our results revealed that H1R and H2R
are propathogenic, while H3R and H4R are anti-pathogenic.
This suggests that combinatorial targeting of HRs may be
an effective disease modifying therapy (DMT) in MS. To
test this hypothesis, we generated H1H2RKO and
H3H4RKO mice and studied them for susceptibility to
EAE. Compared to wild-type mice, H1H2RKO mice
developed a less severe clinical disease course whereas the
disease course of H3H4RKO mice was more severe.
H1H2RKO mice also developed less neuropathology and
disrupted blood brain barrier permeability compared to WT
and H3H4RKO mice. Additionally, splenocytes from
immunized H1H2RKO mice produce less IFN-c and IL-17.
These findings support the concept that combined phar-
macological targeting of HRs may be an appropriate
ancillary DMT in MS and other immunopathologic
diseases.
Departments of Medicine and Pathology, University of
Vermont, Burlington, VT 05405, USA. E-mail: c.teuscher@
uvm.edu
WAKING ACTION OF URSODEOXYCHOLIC ACID
INVOLVES HISTAMINE AND GABAA RECEPTOR
BLOCK
H.L. Haas, Y. Yanovski, S.R. Schubring, Q. Yao, Y. Zhao,
S. Li, A. May, J.S. Lin, O.A. Sergeeva
Since ancient times ursodeoxycholic acid (UDCA), a
constituent of bile, is used against gallstone formation and
cholestasis. We show now that UDCA (35 mg/kg) pro-
motes wakefulness during the active time of the day,
lacking this activity in histamine-deficient mice. In cul-
tured hypothalamic neurons UDCA synchronized the
firing, an effect not present under the GABAAR antagonist
gabazine (10 lM). In histaminergic neurons recorded in rat
slices UDCA reduced amplitude and duration of sponta-
neous and evoked inhibitory postsynaptic currents (IPSCs)
but left the firing unchanged. In acutely isolated mouse
histaminergic neurons UDCA blocked GABA-evoked
currents and sIPSCs starting at 10 lM (IC50 = 70 lM) and
did not affect NMDA- and AMPA-receptor mediated cur-
rents at 100 lM. The potency of UDCA inhibition of
GABAA-receptors was not different between rat and
mouse. Recombinant GABAA receptors composed of a1,
b1-3 and c2L subunits expressed in HEK293 cells dis-
played similar sensitivity to UDCA as native GABAA
receptors. The mutation a1V256S known to reduce the
inhibitory action of pregnenolone sulphate reduced the
potency of UDCA. The mutation a1Q241L, which abol-
ishes GABAAR potentiation by several neurosteroids had
no effect on GABAAR inhibition by UDCA. In conclusion,
UDCA can enhance alertness through disinhibition of the
histaminergic system.
Department of Neurophysiology, Heinrich-Heine-Uni-
versitat, D-40204 Dusseldorf, Germany. E-mail: haas@
uni-duesseldorf.de
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LACK OF EFFECTS BY ABT239, A HISTAMINE H3
RECEPTOR ANTAGONIST, IN HISTAMINE-
DEFICIENT ANIMALS
P. Blandina, G. Provensi, L. Munari, M.G. Giovannini,
T. Garrison, J.R. Koenig, M. Cowart, J. Brioni,
M.B. Passani
Reports of improved cognitive functions with H3 receptor
(H3R) antagonists in animals prompted their use in the
clinic for the potential treatment of cognitive impairments
associated with Alzheimer’s disease, Parkinson’s disease,
schizophrenia and ADHD. H3R antagonists increase cor-
tical ACh release and this effect may relate to their
precognitive properties. Since H3Rs function as auto- and
hetero-receptors that restrict histamine and ACh release,
whether H3R antagonists require an intact histamine
neuronal system to improve cognition is an important
question. Therefore, we evaluated the effects of ABT239
(3 mg/kg,) i.p. administration to histidine decarboxylase
(HDC)-KO mice, which are unable to synthesize hista-
mine, or wild type (WT) littermates on the Object
Recognition Test. In a test given 24 h after the first trial,
ABT239-treated WT mice spent significantly more time
exploring novel rather than familiar objects, whereas sal-
ine-injected WT mice did not, nor did HDC-KO mice.
Also acutely HA-depleted CD1 mice by means of i.c.v.
injection of a-fluoromethy-L-histidine (a-FMH, 5 lg.), an
irreversible inhibitor of HDC, failed to respond to
ABT239 in the same test. To learn the correlation with the
cholinergic tone, we implanted adult, male SD rats with
two contralateral microdialysis probes in the pfCX and
measured ACh and histamine release by HPLC-electro-
chemical or -fluorometric detection. Animals received an
i.c.v. injection of saline or a-FMH (5 lg). Both probes
were perfused with Ringer’s solution (2 ll/min) and
15-min samples were collected. In the controls, ABT239
(3 mg/kg, i.p.) elicited significant increases (2–3 times) of
HA and ACh basal releases (ACh 620 ± 60 fmol/15 min;
HA 50 ± 5 fmol/15 min; ANOVA/Bonferroni). a-FMH-
treated rats displayed both ACh and HA release below
detectable sensitivity before and after ABT239 injection.
These data suggest that ABT-239 requires the integrity of
histamine neuronal system to exert its effects.
Dipartimento di Farmacologia Preclinica e Clinica,
Universitá di Firenze, 50125 Firenze, Italy. E-mail:
patrizio.blandina@unifi.it
THE ANOREXIANT EFFECT
OF OLEOYLETHANOLAMIDE IS MODULATED
BY NEURONAL HISTAMINE
G. Provensi, L. Munari, P. Blandina, N. Galeotti,
M.B. Passani
The modulatory effect of both brain histamine (HA) and
Oleoylethanolamide (OEA) on feeding behaviour is robust,
but nothing is known about the temporal or causal rela-
tionship between HA and OEA in controlling food intake.
To learn if OEA affects feeding behaviour via the hista-
minergic system we measured food consumption in normal
and genetically or pharmacologically HA-deprived mice.
We use sv129 WT and HDC-KO and CD1 male mice that
were food deprived for 12 h and then received pharmaco-
logical treatments. Food consumption was measured every
15 min for the 1st h and at increasing intervals for the
following 24 h. OEA-treated (10 mg/kg i.p. n = 16) WT
mice ate significantly less than vehicle-treated WT mice
(n = 16). However, the anorexiant effect of OEA was
attenuated in HDC-KO mice (n = 28). OEA anorexiant
effect was also attenuated in HA depleted CD1 (5 lg a-
fluoromethyl-histidine i.c.v. n = 20), but not in control
mice (n = 20). Treatment with the H3R antagonist
ABT239 (3 mg/Kg i.p.) potentiated the effect of OEA
(5 mg/kg, i.p. n = 20/treatment). In order to investigate if
changes in neuronal activation are related with the
behavioral differences, we evaluated the c-Fos expression
in HDC-KO and WT (n = 3–5/treatment) mice using
immunohistochemistry in brain areas involved in feeding
behavior: Infralimbic Cortex (IL-Cx), Nucleus Accumbens
(Nac) and Paraventricular Nucleus (PVN). Mice fasted for
12 h were treated with OEA (10 mg/kg i.p.) or vehicle and
sacrificed after 2 hs. OEA treatment decreased the number
of c-Fos+ cell nuclei in the Nac of both HDC-KO and WT
mice. No changes were observed in the IL-Cx of either
genotype. However, in the PVN an increase of c-Fos
expression was observed in OEA-treated WT but not in
HDC-KO mice. Our results indicate that the histaminergic
system is involved in the anorexiant effects of OEA and
that disregulation of PVN neuronal activity may be
responsible for the partial lack of OEA efficacy in HA
deficient mice.
Dipartimento di Farmacologia Preclinica e Clinica,
Universitá di Firenze, 50139, Firenze, Italy. E-mail:
gustavo.provensi@unifi.it
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THE NOVEL HISTAMINE H3 RECEPTOR
ANTAGONIST ST-1283 ATTENUATES ETHANOL
CONSUMPTION AND PREFERENCE IN MICE
B. Sadek, A. Bahi, M. Walter, J.S. Schwed, T. Kottke,
H. Stark
Growing evidence suggests that the central histaminergic
system may exert a modulatory influence on drug addic-
tion, in general, and alcohol-use disorders, in particular.
Thus, a new class of tricyclic nonimidazole-based hista-
mine H3 receptor (H3R) antagonists has been developed
and investigated on ethanol consumption and preference
effects in mice as a model of drug addiction. The com-
pound ST-1283 is a parent ligand for this new class and can
be seen as an ether product of the robust H3R pharmac-
acophore 1-(3-chloropropyl)piperidine and 4-(3-methyl-5-
(pyridin-3-yl)-4H-1,2,4-triazol-4-yl)phenol.
ST-1283 was investigated both in vitro and in vivo. Oral
ethanol, saccharin and quinine intake was assessed in a
two-bottle choice paradigm using escalating concentrations
of alcohol or tasting solutions. In these screenings, 2.5, 5,
10 and 20 % alcohol, 0.04 % and 0.08 % saccharin, and
0.02 mM and 0.04 mM quinine solutions were used.
Compound ST-1283 is a high affinity ligand at human
H3R with subnanomolar affinity (pKi value of 9.62).
Administration of either vehicle or ST-1283 (2.5, 5 and
10 mg/kg, i.p.) dose-dependently and significantly
decreased alcohol consumption and preference without
affecting total fluid intake. More interestingly, vehicle and
ST-1283 (5 mg/kg) treated mice showed similar con-
sumption and preference to increasing concentration of
both sweet and bitter tastes. Our results show that ST-1283
may decrease voluntary ethanol consumption in male mice
by altering its reinforcing effects. The lack of any signifi-
cant effect on quinine and saccharin consumption suggests
that ST-1283 does not simply decrease consumption of all
fluids. These findings provide further evidence for the role
of central H3R in the mediation of voluntary ethanol con-
sumption in mice and may offer further perspectives in the
pharmacotherapy of ethanol addiction.
Kindly supported by the FP7 EU COST Action
BM0806.
Departments of Pharmacology and Anatomy, Faculty of
Medicine & Health Sciences, Al Ain P.O. Box 17666,
United Arab Emirates University, UAE. E-mail:
bassem.sadek@uaeu.ac.ae
SEXUAL AROUSAL, A ROLE OF HISTAMINE
AND OREXINS?
Y. Zhao, C. Anaclet, M. Perier, C. Buda, T.H. Wang,
J.S. Lin
Sexual arousal ensures the necessary waking state allowing
anticipation and performance of sexual activities and so is a
prerequisite for reproduction. We hypothesize that a full
expression of such a behavioural state requires highly
optimal convergent and divergent activities of the brain
arousal systems, notably histamine (HA) and orexins (Ox).
To test our hypothesis, wild type (WT) and histidine-
decarboxylase (Hdc) or OxKO mice were chronically
implanted for EEG and sleep-wake monitoring under
baseline conditions (12 h light/dark cycle) and during the
sexual arousal test. This consisted of introducing a female
mouse for 4 h into the habitual cage of a male mouse; the
two mice were separated by a transparent plexiglass with a
maximal number of holes (diameter = 14–16 mm),
allowing some physical contact, but preventing copulation.
Placement of a male mouse was used as control. The test
was performed during both light and dark phases. Firstly
we found that the presence of a female mouse elicited in
the male a significant increase in waking (+49 % vs.
baseline lightness, n = 32, p \ 0.001). This increase is not
significant if another male was introduced (+10 % vs.
baseline, n = 32, p = 0.2). This sexual arousal appeared to
depend on sex hormones as ovariectomized female mice or
those pretreated with Tamoxifen (an estrogen receptor
antagonist) did not elicit significant sexual arousal in the
male mice. Also male mice, pretreated with Flutamide (an
androgen receptor antagonist), did not show any additional
waking in the presence of a female. Additionally, acute
application of a-FMH (a specific inhibitor of HA synthesis)
or SB-334867 (Ox1-receptor antagonist) both markedly
impaired the sexual arousal in the male mice. Finally, the
sexual arousal appeared intact in Hdc KO mice, whilst Ox
KO mice showed signs of impairment. This all indicates
that both the HA and Ox systems, probably driven by sex
hormones, participate in the promotion of sexual arousal.
Chronic HA loss may be compensated by up-regulated
compensatory mechanisms involving the Ox system.
Integrative Physiology of Brain Arousal Systems, Lyon
Neuroscience Research Center, Faculty of Medicine,
Claude Bernard University, 69373 Lyon, France. E-mail:
lin@univ-lyon1.fr
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INTERACTIONS BETWEEN MAST CELLS
AND STRUCTURAL AIRWAY CELLS
IN THE PATHOGENESIS OF ASTHMA
P. Bradding
Mast cells play a central role in orchestrating the complex
pathophysiological processes underlying asthma and other
allergic diseases. Mast cells located in the airways of
chronic asthmatic subjects are present in a chronically
activated state, with the ongoing release of a plethora of
autacoid mediators, cytokines and proteases. These con-
tribute to airway smooth muscle dysfunction, inflammatory
cell recruitment and tissue remodelling. In asthmatic air-
ways, mast cells infiltrate the airway epithelium, airway
mucosal gland stroma, and the airway smooth muscle
bundles. This therefore places activated mast cells in direct
contact with these dysfunctional airway components.
Recent ex vivo work using primary human airway cells has
identified important bi-directional interactions between
mast cells, airway smooth muscle cells and the airway
epithelium. Manipulating the pathways which facilitate
mast cell-structural cell cross-talk may offer novel
approaches to the treatment of asthma and related allergic
diseases.
Institute for Lung Health, University of Leicester,
Glenfield Hospital, Leicester, LE3 9QP, UK. E-mail:
pbradding@hotmail.com
HISTAMINE CONTRIBUTES TO AN INCREASED
RANKL/OPG RATIO THROUGH ALTERED NR4A
ACTIVITY IN HUMAN CHONDROCYTE CELLS
A. Gilmore, V. Marzaioli, J.P. McMorrow, H. Angerer,
D. Crean, D. Zocco, P.Rooney, D. Veale, U. Fearon,
M. Gogarty, A.N. McEvoy, M.H. Stradner, E.P. Murphy.
Histamine promotes immune complex-induced vascular
leakage, a critical event leading to joint specific autoim-
mune damage in vivo. Increased histamine levels in
synovial fluid, tissue and cartilage of rheumatoid- (RA) and
osteo- (OA) arthritis patients support a role for histamine in
regulating cartilage homeostasis. We aim to elucidate the
histamine receptor-mediated signaling pathways, tran-
scriptional events and target gene expression in human
chondrocyte cells.
Histamine modulation of cartilage destruction was
assessed histologically by Safranin-O staining and proteo-
glycan release. Histamine receptor (HR1,2,3,4) dependent
regulation of nuclear transcription factors NR4A1-3;
receptor activator of NF-jB-ligand (RANKL); and osteo-
protegerin (OPG) mRNA levels were measured in human
primary (n = 8) and SW-1353 chondrocyte cells using
QPCR and selective HR antagonists. sRANKL and OPG
protein levels were determined by ELISA. NR4A protein
levels and trans-activity were evaluated by western,
immunocytochemistry and luciferase reporter assays. Sta-
ble depletion of NR4A1-3 was achieved by lentiviral
transduction of NR4A shRNA.
Primary human chondrocytes express differential steady
state levels of HR1-4 mRNA. In combination with TNFa,
histamine significantly promotes cartilage proteoglycan
depletion. Histamine selectively signals through HR1 and
HR2 to modulate RANKL and NR4A2 expression, with
modulation significantly reduced in cells pre-treated with
inhibitors of PKA, MAPK and NF-jB signalling pathways.
Histamine robustly modulates RANKL, with modest
effects on OPG, leading to significantly increased RANKL/
OPG mRNA and protein ratios. Stable knockdown of
NR4A1-3 expression results in reduced endogenous OPG
levels and the loss of histamine-dependent regulation of
RANKL expression.
Histamine, via HR1 and HR2, may contribute to the
development of inflammatory joint disease by enhancing
the expression ratio of RANKL/OPG through altered
NR4A activity in human chondrocyte cells.
UCD Veterinary Science Centre, University College
Dublin, Belfield, Dublin 4, Ireland. E-mail: evelyn.
murphy@ucd.ie
HISTAMINE DOWNREGULATES SKIN BARRIER
PROTEINS: A POTENTIAL ROLE
IN THE PATHOGENESIS OF ATOPIC
DERMATITIS
M. Gschwandtner, M. Mildner, V. Mlitz, L. Eckhart,
T. Werfel, R. Gutzmer, E. Tschachler
Patients with atopic dermatitis have defects in epidermal
keratinocyte differentiation and skin barrier function.
These defects result either from inherent alterations in the
expression of differentiation-associated proteins and/or the
influence of inflammatory mediators on terminal keratino-
cyte differentiation. Skin mast cells participate in skin
inflammatory reactions by the release of various soluble
mediators, most prominently histamine. Here we studied
the effect of histamine on epidermal keratinocyte differ-
entiation in monolayer cultures, in an in vitro organotypic
skin model and in human skin explant cultures. The
expression of differentiation-associated proteins was
assessed by quantitative realtime-PCR, Western blot and
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immunofluorescence labeling. Histamine reduced the
expression of filaggrin, loricrin, keratin 1 and keratin 10 by
up to 90 % in keratinocyte monolayer culture and in human
in vitro skin models. The influence of histamine on the
expression of differentiation associated proteins was dose-
dependent and only detectable when histamine was added
to the cultures before the onset of keratinocyte differenti-
ation. Accordingly, we did not find a change in the
expression of differentiation-associated proteins in intact
human skin biopsies after ex vivo treatment with histamine.
Furthermore, addition of histamine to organotypic skin
cultures reduced the expression of the cell–cell contact
proteins corneodesmosin and occludin and perturbed the
inside-out barrier function of the epidermis. Taken together
these findings suggest an important role of histamine as
deregulator of epidermal keratinocyte differentiation, con-
tributing to the sustained skin barrier defects observed in
atopic dermatitis.
Department of Dermatology, Research Division of
Biology and Pathobiology of the Skin, Medical University
of Vienna, 1090 Vienna, Austria. E-mail: maria.
gschwandtner@meduniwien.ac.at
LATE SIGNALING EVENTS FOR HISTAMINE
RELEASE BY MAST CELLS
U. Blank
Mast cells are implicated in many chronic diseases with
inflammatory components including allergy, asthma, ath-
erosclerosis etc. and even cancer. Secretion of
inflammatory products, such as histamine, from preformed
sources stored in cytoplasmic granules represents a key
step in the inflammatory process. Within the inflammatory
site, the mast cell must integrate multiple and distinct
activation signals for its secretory response. Therefore,
blocking signaling steps initiated by individual receptors is
not a promising therapeutic approach in inflammation. In
contrast, blocking secretion of its mediators by targeting
the late signaling and vesicular trafficking steps is an
attractive therapeutic strategy. In this talk, I reported on the
progress in the molecular understanding and functional
definition of the late signaling steps that lead to mast cell
degranulation. In particular, I focused on the mast cell
secretory machinery that requires N-ethylmaleimide-sen-
sitive factor attachment protein receptors (SNAREs) to
mediate membrane fusion and accessory regulators. The
results show that the granule-localized SNARE Syntaxin3
and the fusion accessory effector Munc18-2 have com-
plementary roles in degranulation. While Syntaxin 3
directly mediates fusion, its binding partner Munc18-2
controls granule translocation involving its capacity to
interact with the microtubule cytoskeleton. Our results
define a stimulatory Munc18-2 microtubule-dependent axis
coupling the membrane fusion apparatus to receptor sig-
naling and the cytoskeleton to facilitate SG translocation
and SNARE-mediated membrane fusion.
Inserm U699, Paris, F-75018, France; Faculté de
Médecine Paris Diderot, Université Paris 7, Site Xavier
Bichat, Paris, F-75018, France. E-mail: ulrich.blank@
inserm.fr
EICOSANOIDS: PERFORMING LIPIDOMICS
ON ACTIVATED MAST CELLS
G. Nilsson, S. Lundström, R. Saluja, J. Haeggström,
C. Wheelock
Upon activation, mast cells have the capacity to release a
wide variety of mediators, including histamine, proteases,
eicosanoids and cytokines. Eicosanoids are made by oxi-
dation of twenty-carbon essential fatty acids and are
divided into four main families: the prostaglandins, pro-
stacyclins, thromboxanes and leukotrienes. LTB4 and the
cys-leukotrienes C4, D4 and E, as well as the prostaglan-
dins D2 and E2 are well known mast cell mediators. The
objective of this study was to investigate, with a global
approach using lipidomics, the secretion of ninety lipid
mediators representing the cyclooxygenase (COX),
lipoxygenase (LOX) and cytochrome P450 (CYP) meta-
bolic pathways, in two different mast cell populations
(connective tissue-like (CTLMC) and mucosal-like
(MLMC)), activated with the calcium ionophore A23187.
Supernatants were taken 2, 8 and 15 min after activation
and analyzed with LC–MS/MS. Twenty-eight oxylipins
were found above the method limit of quantification in the
CTLMCs and 27 oxylipins in the MLMCs. The most
prominent differences included COX-derived dihomo-
gamma-linolenic acid and arachidonic acid derived prod-
ucts which were all found in *tenfold higher
concentrations in the MLMCs following stimulation at all
measured time points. Notable were also that the sum of
5-LOX mediated compounds (originating from dihomo-
gamma-linolenic acid, arachidonic acid and eicosapentae-
noic acid) were significantly higher in the MLMCs at
2 min (p = 0.008), but significantly higher in the CTLMCs
at 15 min (p = 0.02). By interrogating the compounds
individually and by using multivariate analyses it was
apparent that in particular that AA derived 5-HETE,
5-KETE and the CysLTs most prominently followed this
significant inverse shift in concentration over time. This
study reveals the capacity of mast cells to secrete a high
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variety of oxylipins and also a difference in the ability
between mast cells with different phenotypes.
Karolinska Institutet, 171 76 Stockholm, Sweden.
E-mail: gunnar.p.nilsson@ki.se
THE ALLERGIC EFFECTOR UNIT: MAST
CELLS—EOSINOPHILS INTERACTIONS
REGULATE THE ALLERGIC RESPONSE
F. Levi-Schaffer, M. Elishmereni
Mast cells and eosinophils, the key effector cells in allergy,
co-localize particularly in the late and chronic stages of
allergic inflammation. Recent evidence from our laboratory
has outlined a specialized ‘‘allergic effector unit’’ (AEU) in
which mast cells and eosinophils communicate via both
soluble mediators and physical contact. Our objective was
to evaluate the functional impact of this bi-directional
crosstalk on the cells’ survival and effector activities.
Human and murine mast cells and eosinophils were co-
cultured under various conditions for a few hours or
1–3 days, and in selected experiments cell–cell contact was
blocked. Cell survival, migration and mediator release
were examined. Moreover flow cytometry was used to stain
intracellular signaling molecules and surface receptors.
Mast cells significantly enhanced eosinophil survival
both by soluble mediators and physical contact involving
CD48-2B4 binding. Furthermore resting and IgE-stimu-
lated mast cells led to eosinophil migration and activation
through a paracrine-dependent mechanism. Eosinophils
were found to enhance basal mast cell mediator release and
IgE-mediated mast cell degranulation through CD48-2B4
interactions. Increased phosphorylation of activation-asso-
ciated signaling molecules and enhanced release of tumor
necrosis factor (TNF)-a were observed in long-term
co-cultures. Eosinophils also showed enhanced expression
of intercellular adhesion molecule (ICAM)-1, which
depended on direct contact with mast cells.
In conclusion, our findings describe a new role for mast
cell/eosinophil interplay in augmenting short and long-term
function in both cells, in a combined physical/paracrine
manner. This enhanced functional activity may thus criti-
cally contribute to the perpetuation of the inflammatory
response in allergic conditions.
The Hebrew University of Jerusalem, Jerusalem 91120,
Israel. E-mail: fls@cc.huji.ac.il
DESENSITIZATION OF IgE-DEPENDENT
RESPONSES IN HUMAN LUNG MAST CELLS
FOLLOWING EXPOSURE TO ANTI-IgE
OR ANTIGEN
A. Lewis, P.T. Peachell
Allergen immunotherapy has been employed clinically to
desensitize allergic individuals to allergens. How allergen
immunotherapy works has not been fully elucidated but a
role for regulatory T cells, IL-10 and an isotype class
switch from IgE to IgG have all been suggested. It is less
clear what direct effects immunotherapy has on mast cells.
The aim of this study was to determine the effects of long-
term exposure of human lung mast cells to IgE-directed
ligands on subsequent mast cell responses.
Mast cells were generated by disruption of lung tissue.
Mast cells were further purified by flotation over Percoll
gradients. In some experiments, cells were passively sen-
sitized by incubation (24 h) with JW8-IgE, a
nitrophenacetyl (NIP) specific IgE. To induce desensitiza-
tion, cells were incubated (24 h) with or without anti-IgE
or antigen (NIP-HSA) after which the cells were washed
before challenge (25 min) with anti-IgE or antigen for
histamine release. Histamine release was assayed by
automated fluorometry.
Incubation (24 h) of mast cells with a maximal
releasing concentration (2 lg/ml) of anti-IgE abolished
the subsequent ability of mast cells to release histamine
in response to anti-IgE. This anti-IgE treatment had no
effect on the response of mast cells to the calcium ion-
ophore, ionomycin. Overnight incubation of mast cells
with a concentration of anti-IgE, 100-fold lower than
maximal, also abolished the subsequent response to anti-
IgE (2 lg/ml). Incubation with JW8-IgE led to a *30 %
increase in the expression of IgE by mast cells as
assessed by flow cytometry. Incubation (24 h) of JW8-
IgE sensitized mast cells with a maximal concentration
(10 ng/ml) of antigen abolished the subsequent response
of mast cells to antigen but did not affect the response to
anti-IgE.
These studies demonstrate that overnight exposure to
anti-IgE or antigen desensitizes mast cells to IgE-directed
activation. Moreover, antigen induces a ‘homologous’ form
of desensitization.
University of Sheffield, Sheffield, S10 2RX, UK. E-mail;
p.t.peachell@sheffield.ac.uk
S68 The European Histamine Research Society
123
CHARACTERIZATION OF THE EP RECEPTOR
EXPRESSED BY HUMAN LUNG MAST CELLS
USING NOVEL EP RECEPTOR ANTAGONISTS
L.J. Kay, M. Gilbert, S. Skerratt, N. Pullen, P.T. Peachell
Prostaglandin E2 (PGE2) inhibits histamine release from
human lung mast cells (HLMC). PGE2 mediates its effects
through EP receptors, four of which have been identified.
Our previous studies suggest that PGE2 acts through EP2
receptors in HLMC. The recent development of more
potent and selective EP2 and EP4 antagonists has allowed
us to reappraise EP receptor expression in HLMC.
HLMC were generated by physical and enzymatic dis-
ruption of lung tissue. Cells were incubated with or without
antagonist (50 min), then agonist (10 min) before chal-
lenge with anti-IgE (25 min). Histamine released into the
supernatants was assayed using an automated fluorometric
technique. To determine cyclic-AMP levels, purified
HLMC were incubated (10 min) with agonist, the reaction
terminated using ice-cold ethanol and cyclic-AMP mea-
sured using commercially available EIA kits.
PGE2 inhibited IgE-mediated histamine release in a
concentration dependent manner (pD2, 5.8 ± 0.1). The
EP2-selective agonist butaprost also inhibited histamine
release whereas neither sulprostone (EP1/3 agonist) nor
17-phenyl-trinor-PGE2 (EP1 agonist) had any effect. PGE2
increased total cyclic-AMP levels in HLMC as did buta-
prost. Neither sulprostone nor 17-phenyl-trinor-PGE2 was
effective at increasing cyclic-AMP. Overall these data with
agonists suggest that PGE2 acts on HLMC through EP2 or
EP4 receptors. The effects of selective EP2 (PF-04418948)
and EP4 (CJ-042794) antagonists on the inhibition of his-
tamine release by PGE2 were studied. The EP2 antagonist
PF-04418948 (pKB, 6.78) reversed the inhibition of hista-
mine release by PGE2. By contrast CJ-042794 had no
effect on the inhibitory effects of PGE2.
The use of novel EP selective antagonists confirms that
PGE2 acts through EP2 receptors to stabilize HLMC.
The University of Sheffield, Sheffield, S10 2RX, UK.
E-mail: L.J.Smart@sheffield.ac.uk
EFFECT OF PKC ON HMC-1560 AND HMC-1560,816
MAST CELL LINES ACTIVATION
A. Tobı́o, A. Alfonso, L.M. Botana
Several pathways are related with mast cell activation, such
as calcium (Ca2+), Protein Kinase A (PKA), Protein Kinase
C (PKC) and phosphatases. HMC-1 (Human Mast Cell) is
a human mast cell line which has the c-kit receptor of
tyrosine kinase (TyrK) in its membrane. The natural ligand
of c-kit is the stem cell factor, however, the proliferation of
this cell line is independent of this factor. The two mast cell
lines, HMC-1560 and HMC-1560,816, differ in one mutation
in the c-kit proto-oncogene. Both sublines have the Gly-
560-Val mutation but HMC-1560,816 cell line carries
another mutation, Asp-816-Val in the intracellular side of
c-kit which modifies the conformation of TyrK. Since PKC
is an important mediator of mast cell exocytosis, the effect
of PKC activation was studied in both mast cell lines. PKC
activation increases (HMC-1560) or inhibits (HMC-1560,816)
mast cell exocytosis depending on cellular model. STI571
(imatinib mesylate) is a tyrosine kinase inhibitor and thus
inhibits kinase activity of c-kit. STI571 failed to inhibit
HMC-1560,816 cell line proliferation, whereas it is effective
in HMC-1560 mast cell line. The effect of STI571 and PKC
activation was analyzed in this work. An opposite STI571
effect on PKC expression was observed in HMC-1560 and
HMC-1560,816 cell lines. Thus, STI571 increases classical
PKCs expression in HMC-1560,816 but STI571 does not
have this effect in HMC-1560. In addition, the STI571
effect in HMC-1560,816 is blocked when PKC is activated.
Moreover, cytosolic expression of PKCd, an isoform
related with apoptosis, was studied in both cell lines.
STI571 decreases cytosolic PKCd expression in HMC-1560
while the compound does not affect protein expression in
HMC-1560,816. Finally, STI571 treatment induces PKCd
translocation to the nucleus in HMC-1560 cells, whereas in
HMC-1560,816 cell line, this translocation does not occur.
Pharmacology Department, University of Santiago de
Compostela, Lugo 27002 Spain. E-mail: luis.botana@
usc.es
NOVEL MAST CELL-STABILISING AMINE
DERIVATIVES OF 3,4 DIHYDRONAPHTHALEN-
1(2H)-ONE AND 6,7,8,9-TETRAHYDRO-5H-
BENZO[7]ANNULEN-5-ONE
J.W. Barlow, T. Zhang, O. Woods, J.J. Walsh
Mast cells are densely granulated cells traditionally asso-
ciated with the pathogenesis of allergic reactions.
However, their additional roles are increasingly being
recognised. As examples, mast cells are involved in cell-
mediated immune reactions, are a component of the host
reaction to infection, and have functions in tumour angio-
genesis and tissue repair. The aim of this work was to
conduct an assessment of the potential anti-allergic activity
of a novel series of cyclic amino derivatives of tetralone
and benzosuberone. The primary steps in their synthesis
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involved a Wohl-Ziegler bromination step followed by a
substitution reaction with the appropriate amine. Alkyl-
ation of the secondary amines thus formed was effected
with a series of alkyl halides to afford the title compounds
for evaluation. Percoll-purified rat peritoneal mast cells
were used for the in vitro studies which employed com-
pound 48/80 and calcium ionophore A231867 to induce
degranulation. The in vivo passive cutaneous anaphylaxis
assay was used to evaluate the most active compounds
from the in vitro work. In vitro investigation of the mast
cell stabilising activity revealed that optimal activity
appeared to reside in a tertiary amine bearing either the
parent bicyclic system, an unsaturated cyclohexene, or a
benzyl or substituted benzyl motif. It further appears that
the unsaturated alicyclic system on nitrogen is critical for
in vivo activity. This suggests that, while ring expansion of
the hydroaromatic core is permissible without loss of
activity in vivo, there must be an unsaturated alicyclic
component.
School of Pharmacy and Pharmaceutical Sciences,
University of Dublin, Trinity College, Ireland. E-mail:
JJWALSH@tcd.ie
ALLERGIC AIRWAY INFLAMMATION IN H2R
KNOCKOUT MICE: INCREASED
SUSCEPTIBILITY INDEPENTLY OF TREG CELL
NUMBERS
R. Ferstl, P. Konieczna, M. Ziegler, R. Frei, C.A. Akdis,
L. O‘Mahony
More than 15 % of people in the western population suffer
from allergy or asthma. In order to develop new and more
effective therapies, a better understanding of the molecular
mechanisms underpinning this chronic disease is required.
Histamine, released by activated mast cells and immune
cells, causes many of the symptoms associated with allergy
and asthma. Histamine is recognized by 4 different hista-
mine receptors (H1R-H4R), each inducing its own
signaling cascade. H2R is known as an immune regulatory
receptor but its role in allergy is not well described. We
used a murine model of allergic airway inflammation
similar to asthma to investigate the role of H2R in this
disease. For this female H2R-/- mice and BALB/c wt mice
were sensitized i.p. and OVA-aerosol challenged. Mice
lacking H2R showed significant increased cell numbers in
bronchoalveolar lavages, mainly due to elevated eosinophil
numbers. Lung histology confirmed increased inflamma-
tory scores in knockout animals. Furthermore, in vitro
re-stimulation with OVA induced higher Th1 and Th2
cytokine release from single cell suspensions from lungs,
spleen and lymphnodes. Taken together, H2R-/- mice
develop more severe allergic airway inflammation.
CD4 + CD25 + Foxp3 + Treg numbers were evaluated by
flow cytometry in Peyer’s patch, mesenteric lymph nodes,
spleen, lung-draining lymph nodes, lung tissue and bron-
choalveolar lavages. Treg numbers were similar in
wildtype and knockout animals at all sites, with a tendency
towards increased Treg numbers in H2R-/- inflamed
lung, perhaps related to altered anti-inflammatory com-
pensatory mechanisms in the H2R-/- animals.
In conclusion, H2R is an important immunoregulatory
receptor that influences the severity of allergic airway
inflammation in murine models. In addition, the increased
severity of disease was not associated with decreased Treg
numbers suggesting that other immune cell populations
may be directly influenced by histamine signaling through
the H2R.
Swiss Institute of Allergy and Asthma Research (SIAF),
University of Zurich, Davos, Switzerland. E-mail:
Ruth.Ferstl@siaf.uzh.ch
DIFFERENTIAL ROLE OF HYPOXIA-INDUCIBLE
FACTOR-1 IN HUMAN MAST CELL
AND BASOPHIL RESPONSES
B.F. Gibbs, I. Yasinska, V.V. Sumbayev
Hypoxia-Inducible Factor-1 (HIF-1) facilitates cellular
adaptation to hypoxic conditions, which also occur during
allergic inflammation, by controlling angiogenesis and
glycolysis. Our aims were to address whether there is an
overarching principle of HIF-1 involvement in controlling
the release of histamine as well as the synthesis of angio-
genic and inflammatory cytokines from human mast cells
and basophils activated by IgE-dependent or innate
immune triggers. Purified human basophils and LAD2
human mast were used for investigations of FceRI and
Toll-like receptor (TLR) ligand-induced responses. Real-
time PCR, Western blotting, ELISA, fluorometry and lu-
minometry were employed to assess the role of HIF-1 on
the ability of these cells to release histamine, pro-allergic
and angiogenic cytokines as well as to generate ATP. Mast
cells expressed high background levels of HIF-1a, which
were not significantly enhanced by IgE-, TLR-, or stem cell
factor-mediated stimulation. Mast cell survival and cyto-
kine synthesis was, however, markedly reduced by HIF-
1alpha knockdown following both IgE- and TLR ligand
stimulation. HIF-1 was also involved in IL-4 secretion
from basophils caused by IgE-dependent triggering but not
by the TLR2 ligand peptidoglycan (PGN). In contrast to
cytokine synthesis, histamine release in both basophils and
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mast cells was not controlled by HIF-1. We conclude that
HIF-1 accumulation plays a crucial role in sustaining
human allergic effector cell survival and function. This
transcription complex facilitates the generation of both pro-
angiogenic and inflammatory cytokines in mast cells but
has a differential role in basophil stimulation comparing
innate immune stimuli with IgE-dependent triggering.
Medway School of Pharmacy, University of Kent, Cen-
tral Avenue, Chatham Maritime, ME4 4TB, UK. E-mail:
B.F.Gibbs@kent.ac.uk
THE EFFECTS OF HISTAMINE
AND 4-METHYLHISTAMINE ON THE OXIDATIVE
BURST OF HUMAN LEUKOCYTES
O. Vasicek, A. Lojek, M. Ciz
Histamine plays an important role in immune system dis-
orders and allergies. Since studies about the relation of the
newly discovered histamine H4 receptor with functional
properties of phagocytes and phagocyte-derived reactive
oxygen species (ROS) generation are very rare, we focused
on evaluating histamine effects on functional activity of
human leukocytes and on antioxidant properties of
histamine.
The ability of isolated leukocytes or leukocytes in the
whole blood of healthy human volunteers to produce ROS
after histamine or the H4 receptor agonist 4-methylhista-
mine treatment (10-8–10-4 M) was tested by luminol-
enhanced chemiluminescence (CL). Antioxidant properties
of both compounds were measured by CL (TRAP) and
fluorescence (ORAC) analyses.
According to their basic level of spontaneous ROS
production in whole blood and their responsiveness to the
histamine treatment, the healthy volunteers could be
divided into three groups. Group 3 is characterised by
higher level of ROS production. In this case, both hista-
mine and 4-methylhistamine dose-dependently inhibited
the CL response of phagocytes. While there was no sig-
nificant effect on the ROS production by either of the
compounds in Group 2, both compounds in the lowest
concentrations tested significantly increased ROS pro-
duction in Group 1. Then the ROS production gradually
decreased with increasing concentrations of tested com-
pounds reaching the level of the control when the highest
concentration of histamine or 4-methylhistamine was
used. The differences among groups and the effects of
histamine and 4-methylhistamine were less profound in
isolated leukocytes. Neither histamine nor 4-methylhista-
mine had any antioxidant potential against reactive
oxygen species.
It can be concluded that histamine modulates the
activity of cells of the immune system, especially of
phagocytes, in a concentration dependent manner. H4
receptors could at least partially play a role in this
phenomenon.
Institute of Biophysics, Academy of Sciences of the
Czech Republic, 612 65 Brno, Czech Republic. E-mail:
milanciz@ibp.cz
THE TH-1-ASSOCIATED CYTOKINE CXCL10/IP-10
IS DOWNREGULATED IN MONOCYTES
AND MYELOID DENDRITIC CELLS: AN EFFECT
POSSIBLY MEDIATED VIA DIFFERENT
HISTAMINE RECEPTORS IN BOTH CELL TYPES
F. Jantzen, T. Werfel, R. Gutzmer
Histamine has been shown to influence inflammatory pro-
cesses by modulating the cytokine expression of antigen
presenting cells (APC), e.g. by downregulation of the Th1-
associated cytokine IL-12. In this study, we analysed the
effects of histamine on CXCL10/IP-10 (interferon gamma
inducible protein),—another Th1-associated cytokine pro-
duced by APC.
Monocytes and myeloid dendritic cells (mDC) were
isolated from human PBMC. After pre-incubation with
different histamine concentrations (10-5–10-10 mol/l) or
4-methylhistamine (10-5 mol/l) the cells were stimulated
with PolyI:C for different time periods (2–24 h). Super-
natants were analysed by protein array for the expression of
several cytokines. The concentration of IP-10 in the
supernatants was quantified by ELISA. To analyse which is
the responsible histamine receptor we pretreated the cells
with different receptor antagonists for 30 min (H2R: rani-
tidine, H4R: JNJ7777120).
A pre-stimulation with histamine caused a significant
decrease of PolyI:C-induced expression of CXCL10 in a
time- and dose-dependent manner in monocytes and mye-
loid dendritic cells. We observed this effect in protein
arrays and ELISA with cell supernatants. Additional
blocking with specific H2R and H4R antagonists showed
that the observed effect is solely mediated via H2R in
monocytes, but appears to be mediated also via H4R in
mDC.
Taken together our results show that the Th1-associated
chemokine CXCL10 is downregulated by histamine in
monocytes and mDC. There appear to be differences in the
histamine receptor responsible for this effect between
monocytes and mDC, which is currently under investiga-
tion. This represents a new mechanism how histamine
fosters a Th2 milieu by downregulating Th1 cytokines.
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Department of Dermatology and Allergy, Division of
Immunodermatology and Allergy Research, Hannover
Medical School, DE-30625 Hannover, Germany. E-mail:
Jantzen.Franziska@mh-hannover.de
EFFECTS OF 2,4-DIAMINOPYRIMIDINE H4R
LIGANDS ON HISTAMINE LEVELS
IN THE NORMAL AND INFLAMED RAT
CONJUNCTIVA
S. Chalkiadakis, M. Walter, H. Stark, E. Tiligada
The novel concept of the immunomodulatory role of his-
tamine (HA) is supported by the primary distribution of the
recently identified HA H4 receptor (H4R) in immune cells.
This study aimed to investigate the effects of 2,4-diami-
nopyrimidine derivatives with different efficacies on the
putative H4R-mediated automodulatory HA function in the
normal and inflamed rat conjunctiva. Male Wistar rats of
300–350 g were maintained under controlled conditions.
A 10 ll drop of the 4-diaminopyrimidines ST-994, ST-
1006 and ST-1012 (0.1–10 mM dissolved in normal saline)
was applied topically into the lower conjunctival fornix of
one eye, either alone or after challenge with the mast cell
degranulator C48/80 (100 mg/ml). The contra-lateral eye
served as the respective control, while ketotifen was used
to validate the experimental model of C48/80-induced
conjunctivitis. The animals were sacrificed 20 min after
compound administration, the conjunctivae were removed
(licence K/2889/11 EL) and HA levels were determined
fluorometrically. Topical administration of the H4R neutral
antagonist ST-994 resulted in dose-related increases in the
conjunctival HA content, while the partial agonist ST-1006
and the inverse agonist ST-1012 tended to decrease HA
levels at high and low doses, respectively. ST-1012 did not
reverse the C48/80-induced decreases in the conjunctival
histamine content in agreement to the results obtained
following topical administration of the H4R inverse agonist
JNJ7777120 in C48/80-induced conjunctivitis. These data
point to a constitutive H4R-meditated automodulatory HA
function in the rat conjunctiva. The connection to imme-
diate mast cell degranulation and the elucidation of the
components intersecting H4Rs and automodulatory HA
functions under normal and inflammatory conditions is
currently under intense investigation.
This work was supported by FP7 EU COST Action
BM0806 & MW performed COST-STSM-BM0806-8231
(DE to EL)
Depatment of Pharmacology, University of Athens
Medical School, 11527 Athens, Greece. E-mail: aityliga@
med.uoa.gr
A MULTI-APPROACH STRATEGY TO REVEAL
THE ROLES OF HISTAMINE (HIS)-RELATED
ELEMENTS IN RARE DISEASES
F. Sánchez-Jiménez, A. Pino-Ángeles, A. Reyes-Palomares,
C. Acosta, J. Caro-Astorga, R. Castro-Oropeza,
E. Melgarejo, J.L. Urdiales
Alterations in the HIS-related elements have been found in
widely spread human pathologies (anaphylaxis and other
inflammatory responses, peptic ulcer, neurological and
cardiovascular disorders and cancer progression, etc.). For
all of these reasons, HIS can be considered the most ver-
satile biogenic amine, playing many different (and
sometimes antagonistic) roles in mammalian physiology.
Rare diseases (RDs) are very low-prevalence pathologies
(\2 patients/1,000 inhabitants). More than 6000 RDs
([20 9 106 patients in Europe) have been described. One
of the major problems for RD therapy is the lack of
interest to invest in R&D on drugs useful for a small
number of patients. Inflammation and neurological
abnormalities are commonly included as causes or symp-
toms of many RDs. The initial hypothesis underlying this
work was that HIS must be involved in causes/symptoms
of many RDs. In fact, HIS-related genes underlie the most
common properties for typical disease related genes.
Systems Biology resources, text mining technologies,
metabolic and molecular modeling, in combination with
experimental validation, provide efficient ways to extract
emergent knowledge from the integration of previous
fragments of information. By applying this strategy, we
are developing several studies based on biocomputational-
driven hypotheses with the aim to unveil the putative
usefulness of HIS metabolism/signaling modulators in
diagnosis, prevention or therapy of these identified RDs. In
addition to basic new information on histidine decarbox-
ylase dimerization and its usefulness for selective
intervention of inflammatory and neurological RDs,
interesting information has emerged on the putative
involvement of histamine in several RDs, for instance,
Tourette and Sotos syndromes, among others.
Supported by Grants SAF2011-26518 & CVI-6585.
CIBERER that is an initiative of ‘‘Instituto de Salud
Carlos III’’.
Departamento de Biologı́a Molecular y Bioquı́mica.
Universidad de Málaga, CIBER de Enfermedades Raras
(ISCIII), Malaga, 29071, Spain. E-mail: kika@uma.es
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Chemical and genetic aspects of histamine, its receptors and enzymes
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HISTAMINE H4 RECEPTOR: LIGAND, BINDING
AND ACTIVATION
H. Stark
The youngest member of the family of histamine receptor
subtypes, the histamine H4 receptor (H4R), has received
massive interest due to its influence on inflammatory and
immunomodulatory processes.
With respect to drug development some different lead
structures have already been described and at least one,
perhaps more, have been advanced to clinical trials.
Despite this rapid progression there are still some phar-
macological tools which are missing since the thus far
adopted reference compounds give in different assays
conflicting results. This clearly shows that we lack some
understanding in the ligand interaction, the efficacy, and
the cross-talk in this receptor.
Different classes of H4R ligands will be discussed with
an emphasis on the 2-aminopyrimidines which may have
the highest number of compounds in this class in connec-
tion to strong variance in affinity as well as in efficacy,
especially when different species being taken into account.
Structurally strongly related 2-aminopyrimidines with
comparable affinities, but large differences in efficacies
have been investigated in molecular dynamic simulations
proposing a different binding mode within this class of
compounds depending on their efficacies as partial agonists
or inverse agonists.
We propose a ‘‘pseudo ionic lock’’ motif in hH4R that may
affect receptor activation, but is not responsible for the high
constitutive activity of the receptor. The latter may be caused
by a salt bridge between transmembrane domains V and VI
which can be seen as a widespread motif in aminergic GPCRs.
Kindly supported by the Hessian LOEWE programs
NeFF, OSF and AFA as well as by the EU COST Actions
(BM0806, BM1007 and CM1103).
Goethe University, Institute of Pharmaceutical Chem-
istry, Biocenter, Max-von-Laue-Str. 9, 60438 Frankfurt,
Germany. E-mail: h.stark@zafes.de
INFLUENCE OF THE LIPOPHILIC PART
OF 3-(1H-IMIDAZOL-4-YL)PROPYL
CARBAMATES ON HISTAMINE H3/H4 RECEPTOR
AFFINITY, SELECTIVITY, AND POTENCY
M. Więcek, T. Kottke, R. Seifert, H. Stark,
K. Kieć-Kononowicz
Human histamine H4 receptor (hH4R) is the newest hista-
mine receptor and is preferentially active on hematopoietic
and immune cells. Due to high structural similarities
between H3R and H4R it is not surprising, that numerous
imidazole-containing H3R ligands have also significant
affinity at the H4R. Such compounds are considered as new
pharmacological tools and could possess therapeutic profile
in therapy of inflammatory and immune disorders.
Recently we described branched alkyl, alkenyl and
cycloalkyl carbamates of 3-(1H-imidazol-4-yl)propanol
that showed both H3R antagonist/inverse agonist activity
and improved H4R affinity. In expansion of the investiga-
tion for histamine H3 and/or H4 receptor ligands in this
class of compounds and structural requirements for affinity
at these receptors, we introduced different substituents in
eastern part of molecule. We synthesized series of com-
pounds possessing (un)substituted phenylalkyl or
(un)substituted phenoxyalkyl group at carbamate nitrogen.
The compounds were tested for their affinities at hH3R
(by competition binding experiments with [125I]iodopr-
oxyfan on membranes of CHO-K1 cells stably expressing
hH3R) and hH4R (by [
3H]histamine replacement assay on
membranes of Sf9 cells, co-expressing hH4R with Gai2 and
Gb1c2 subunits). Some compounds were also tested for
their H3R potency in vivo by quantification of endogenous
Ns-methylhistamine level in the brain of Swiss mice after
oral treatment with test compounds.
All tested compounds exhibited good affinity for hH3R
with Ki values in range from 30 to 150 nM. Most com-
pounds were also active in vivo. In respect to hH4R affinity
in this group of compounds there are some without affinity
to this receptor (selective for H3R) and others with affinity
in the micromolar concentration range (Ki = 600–4,868
nM).These results indicated that selectivity for hH3R over
hH4R among imidazole-derivatives is possible to achieve.
Kindly supported by the COST Action BM0806, Grant
No. 594/N-COST/2009/0.
Department of Technology and Biotechnology of Drugs,
Jagiellonian University Medical College, Medyczna 9, 30-
688 Kraków, Poland. E-mail: mfkonono@cyf-kr.edu.pl
COMBINATION OF PROTOTYPICAL HISTAMINE
H3 AND H4 RECEPTOR PHARMACOPHORES
A. Schreeb, S. Schwed, L. Weizel, H. Stark
The human histamine H3 and H4 receptor subtypes (hH3R,
hH4R) are structurally highly related G protein-coupled
receptors. Preclinical and clinical data hint at an involve-
ment of the two receptors in diseases like itch and pain.
According to the structural requirements responsible for
affinity and selectivity for both receptor subtypes, we inves-
tigated the combination of 2-aminopyrimidines and related
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structures (for H4R) with the well-established and robust (3-
piperidinopropoxy)phenyl pharmacophore (for H3R). In an
effort to design new structurally hybrid compounds, a novel
series of substituted pyrimidines were synthesized.
The compounds were prepared by microwave-assisted
aromatic nucleophilic substitution reactions of either
2-amino-4,5-dichloropyrimidine or 2,4-dichloropyrimi-
dine. The in vitro receptor binding properties were obtained
by radioligand displacement assay on HEK-293 cells stably
expressing the hH3R and on Sf9 cells transiently expressing
the hH4R (co-expressed with Gai2 and Gb1c2 subunits).
Slight structural changes of the hH4R scaffold evoked
severe changes in hH4R affinity, although the 2,4-diamino-
pyrimidine scaffold can be found in many potent hH4R
ligands. In contrast, hH3R affinity has barely been affected by
introducing the pyrimidine-related motif on the H3R phar-
macophore. Novel compounds with hH3R binding properties
in the nanomolar concentration range have been achieved.
This work was kindly supported by the Else Kröner-
Fresenius Foundation (TRIP), the EU COST Actions
(BM0806, BM1007 and CM1103), and the Hesse LOEWE
Schwerpunkte NeFF, OSF and AFA.
Goethe University, 60438 Frankfurt, Germany. E-mail:
h.stark@zafes.de
HIGHLY AFFINITY DIMERIC H3R LIGANDS
INDICATE RECEPTOR DIMERS/OLIGOMERS
K. Wingen, J.S. Schwed, L. Weizel, E. Proschak, H. Stark
Despite recent progress in clinical trials with hH3R inverse
agonists/antagonists, the molecular complexity of H3R
signaling leaves many open questions, e.g. the impact of
receptor (homo)dimerization/oligomerization.
We developed a homology model of the hH3R based on
the X-ray structure of the hH1R which was then used to
build up a hH3R homodimer model taking advantage of the
crystallographic X-ray structure of dimeric CXCR4. This
model has been the basis for the search of the optimal
linker length for divalent H3R ligands which stabilize
dimeric receptors by lipophilic bridging between the
pharmacophoric elements within the transmembrane
regions. The Asp114 binding pockets have been taken as
basic orientation for the measurement of a distance of
about 40 Å in pharmacophoric elements. Taking into
account some flexibility in the linking chain with different
lipophilic transmembrane interactions a spacer of six to 16
methylene units may be acceptable in this model.
Different derivatives of the antagonist JNJ-5207852 have
been prepared with different linking elements as we have
shown in previous studies that numerous structural
variations can be performed maintaining high hH3R affin-
ity. The monomeric precursors have been linked to dimeric
compounds by peptide like amide bonds in a tail-to-tail or
tail-to-head manner. Most of the di- and structurally related
monovalent compounds showed (with a displacement
assay) binding affinities in a comparable nanomolar con-
centration range, but exhibited strong differences in Hill
slope, suggesting a different mode/ratio in receptor binding.
This work was supported by the EU COST Actions
(BM0806, BM1007 and CM1103) and the Hesse LOEWE
Schwerpunkte NeFF, OSF and AFA.





IN TISSUES AND PLASMA
S. Rajtar Osredkar
So far we have been able to measure histamine level in
many different ways, including capillary electrochroma-
tography, radioenzymatic assay, enzyme immunoassay, gas
chromatography, spectrofluorometry and high performance
liquid chromatography (HPLC) and others. Most of these
techniques, however, suffer from some disadvantages, such
as low specificity and sensitivity, possible appearance of
interfering substances, time consuming sample preparation
or expensive instrumentation. Histamine concentrations
that provoke life threatening systemic effects are very low,
often just above the detection limit of above mentioned
methods. We are presenting here the improved method for
measuring histamine and methylhistamine at ng/ml
concentrations in biological samples. We will describe the
set-up of the ultrahigh performance liquid chromatography
(U-HPLC) assay for histamine and methylhistamine mea-
surement in guinea pig plasma and tissues. We determined
the sensitivity, accuracy, repeatability and detection limit
of U-HPLC. The performance of U-HPLC on column with
a 2.6 lm core–shell particle was also compared with HPLC
on column with standard particle size (5 lm). After opti-
mising pressure, mobile phase and concentration of
derivatisation agent, we attained the capability of detecting
very low histamine and methylhistamine concentration,
even 2 ng/ml. To reach this detection limit, deproteiniza-
tion, ion exchange chromatography procedure as well as
extraction with acetonitrile and methanol was necessary.
Histamine and methylhistamine retention times were 4.1
and 6.4 min, respectively, which is rather faster than on
column with standard particle size (retention times 12 and
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16 min, respectively). The most important advantages of
U-HPLC are high repeatability and low detection limit,
however, sample preparation is time consuming and needs
further improvement.
Institute of Pharmacology and Experimental Toxicol-
ogy, Faculty of Medicine, University of Ljubljana, 1000
Ljubljana, Slovenia. E-mail: simona.rajtar@mf.uni-lj.si
INTRAVENOUS INFUSION OF ASCORBIC ACID
REDUCES PLASMA HISTAMINE LEVELS
A.F. Hagel, C.M. Layritz, W.H. Hagel, H.J. Hagel,
E. Hagel, A. Rosenberg, W. Dauth, J. Kressel,
M.F. Neurath, M. Raithel
Histamine (HA) plays an important role in allergic and
inflammatory diseases. HA intolerance is also an important
clinical condition. Degradation of HA in humans occurs
through the enzymes histamine-N-methyltransferase
(HNMT) and diamine oxidase (DAO).
Ascorbic acid is an essential vitamin and antioxidant
agent. An inverse relationship between plasma HA and
ascorbic acid concentrations has been found in guinea pigs
and test humans.
Test persons (90) were treated with 7.5 g ascorbic acid
(Pascoe, Giessen) intravenously over 60 min. Directly
before and 1 h after infusion, plasma HA levels and DAO-
activity were measured using an ELISA technique (IBL,
Hamburg and Sciotech, Tulln).
Plasma HA concentrations were distributed over a range
from 0.15 to 0.75 ng/ml. A statistically significant decline
(of 34.9 %) was seen in all test persons after ascorbic acid
infusion (p \ 0.00005). After separating test individuals
into subgroups with and without allergic diseases, both
groups showed a significant decline in HA concentration
(no allergy: 30.4 %; allergics: 47.9 %). Interestingly,
ascorbic acid had a significantly greater impact on HA
concentrations in individuals with allergic diseases
(p = 0.021) compared to controls. However, DAO levels
did not show any difference before and after ascorbic acid
infusion (127.74 vs. 110.91 HDU/ml, p = 0.385).
This study showed a direct impact of ascorbic acid
administration on plasma HA levels. Ascorbic acid reduced
plasma HA levels significantly in allergic and non-allergic
patients. Patients with allergic diseases showed a statisti-
cally greater decline in HA levels. Thus, we can confirm
previous results found in guinea pigs and give some
objective data for the possible future use of ascorbic acid
infusion in the treatment of HA intolerance, mastocytosis,
polyvalent allergies, inflammatory disease states etc. Since
no change in DAO activity was found, the mechanisms
behind the beneficial action of ascorbic acid remain to be
further explored.
Med. Clinic I, University Erlangen, Ulmenweg 18,
91054 Erlangen, Germany. E-mail: Alexander.hagel@uk-
erlangen.de
HDC-GFP TRANSGENIC MOUSE
H. Ohtsu, A. Sato, T. Moriguchi, J. Takai, M. Yamamoto
In vivo activity of histamine has been studied well enough
to stimulate discussion in the last decade, partly because of
the generation of various kinds of gene manipulated mice.
On the contrary, the source of histamine in the physio-
logical and pathological situation has not been studied as
well, partly because of the lack of useful reporter mice.
We aimed to prepare the reporter mice for histidine
decarboxylase (HDC) gene by using a bacterial artificial
chromosome (BAC) construct to mimic the expression of
the gene. It will reduce the difficulty of gene-expressing
cell identification.
We used the longest BAC clone, RP23-40N15, in a
library of CHORI for HDC gene. This HDC-BAC clone
was homologously recombinated with the plasmid con-
taining the HDC-promoter, GFP gene, and HDC gene
without 1st exon, and 30 region, in E. coli strain EL250.
Isolated BAC DNA was injected into a fertilized egg to
produce a BAC transgenic mouse.
FACS analysis of peritoneal cells of the transgenic mice
showed GFP high-expressing cells in the Mac1- and/or c-kit-
positive cell fraction indicating that peritoneal macrophages
and/or mast cells were positive for GFP expression.
Newly generated BAC-based transgenic mice are
promising reporter mice to investigate the transcriptional
expression of the HDC gene.
Tohoku University, Graduate School of Engineering,
Sendai, 980-8579, Japan. E-mail: hiroshi.ohtsu@qse.tohoku.
ac.jp
COMPARISON OF THE PHARMACOLOGICAL
AND SIGNALING PROPERTIES OF WILD-TYPE
AND A280V MUTANT HUMAN HISTAMINE H3
RECEPTORS EXPRESSED IN CHOK1 CELLS
C. Flores-Clemente, A. Osorio-Espinoza,
J. Escamilla-Sánchez, J.M. Arias-Montaño,
J.A. Arias-Montaño
Histamine H3 receptors (H3Rs) modulate at the pre-
synaptic level the release of histamine and other
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neurotransmitters. In a patient suffering from the Shy-
Drager syndrome an Ala to Val exchange at amino acidic
position 280 (A280V) in the third intracellular loop was
identified. Further, this receptor polymorphism has recently
been described as a risk factor for migraine in a Mexican
population. The third intracellular loop of G protein-cou-
pled receptors is crucial for G protein-coupling and this
variation may thus be relevant for the signaling triggered
upon receptor activation. In this work, we set out to com-
pare the pharmacological and signaling properties of wild-
type and A280V mutant human H3Rs expressed in CHOK1
cells.
The A280 V mutant receptor was generated by over-
lapping extension PCR amplification using as template the
human H3R of 445 amino acids (hH3R445) sub-cloned into
the vector pCIneo, and verified by automated sequencing.
The wild-type and mutant hH3Rs were stably expressed
at similar densities (203 ± 34 and 173 ± 26 fmol/mg
protein, respectively, n = 5) by CHOK1 cells after lipo-
fectamine-mediated transfection and geneticin-driven
clone selection. There were no significant differences
between both receptors in their affinities for H3R ligands
([3H] N-a-methyl-histamine, histamine, R-a-methylhistamine
and clobenpropit). The H3R agonist R-a-methylhistamine
inhibited forskolin-induced cAMP accumulation, but the
maximum response attained in cells expressing the wild-
type hH3R was significantly larger (students t test) than that
corresponding to the mutant receptor (-43.3 ± 6.6 and
-24.5 ± 2.7 %, respectively, n = 8), while the pIC50
values were not different (-8.77 ± 0.17 vs. 8.42 ± 0.14).
These preliminary data indicate that the A280V muta-
tion modifies the signaling properties of the human H3
receptor without altering agonist binding.
Supported by Cinvestav and Conacyt (grant 128205 to
J.A.A.M).
Departmento de Fisiologia, Biofisica y Neurociencia,
Centro de Investigacion y de Estudios Avanzados (Cinve-
stav) del IPN, Zacatenco, 07360, Mexico, DF, Mexico.
E-mail: ceciflores_10@hotmail.com
INTERACTION OF N-METHYL PIPERAZINE
DERIVATIVES WITH PTEN PROMOTER
P. Kechagioglou, R. Papi, G. Latacz, D.A. Kyriakidis,
K. Kieć-Kononowicz
The aim of this study was the exploration of the interaction
of N-methylpiperazine derivatives with the promoter of
PTEN (phosphatase and tensin homolog deleted on chro-
mosome ten). PTEN is one of the most frequently mutated
tumor suppressor genes in human cancer, with a frequency
approaching that of p53. The protein encoded by PTEN is a
tyrosine phosphatase. Although it can dephosphorylate
proteins, its primary targets are highly specialized mem-
brane lipids, mainly facilitating the removal of the
phosphate group from the inositol rings. The examined
compounds were synthesized with histamine H4R targeting
activity.
PTEN promoter was amplified together with exon-1
using human genomic DNA that was extracted from blood.
Each compound, at a final concentration of 2 mM, was
incubated with an equal amount of PCR product at 24 C
for 30 min. Subsequently the mixtures were electrophore-
sed on 2 % w/v agarose gel.
TR-33 reduced the motility of the PCR product to a
greater extent than TR-18 and TR-19. We conclude, that in
the group of triazines the substitution of the 3-pyridyl in
TR-33 with the 4-b romophenyl in TR-18 reduced the
activity. The reduction was even greater when the
2-naphthylmethyl was introduced in TR-19. No effect was
observed with TR-20 and TR-28 that differ also with aryl
substituent from TR-33. Comparing KB-1, KB-3, KB-8
and KB-28.2 the best result was observed with KB-1 fol-
lowed by KB-3 and KB-8, while KB-28.2 had no effect. It
is interesting to notice that KB-1 and TR-33 possess similar
structures with aryl substituent directly connected with
triazine core. The best results were obtained among amides
with CJ-7, L-58 and L-11. CJ-16, CJ-22 and L-60 had no
effect.
In conclusion, some of the N-methylpiperazine deriva-
tives influenced the motility of PTEN promoter. This
implied an interaction with the promoter that could regulate
PTEN expression. A favourable SAR for this effect is
suggested.
This work was kindly supported by the COST Action
BM0806
Collegium Medicum Jagiellonian University, Depart-
ment of Technology and Biotechnology of Drugs,
Medyczna 9, 30-688 Krakow, Poland. E-mail: glatacz@
cm-uj.krakow.pl
DIAMINE OXIDASE IS PRESENT IN SEMINAL
PLASMA FROM MAN BUT NOT IN THAT
FROM OTHER MAMMALS
F. Ahrens, J. Feurle, H.G. Schwelberger
Human seminal plasma contains considerable amounts of
diamine oxidase (DAO). However, information on the
function of human seminal plasma DAO, on DAO in
seminal plasma from other mammals and on the presence
of the second histamine-inactivating enzyme, histamine
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N-methyltransferase (HMT), in sperm is scarce. Therefore,
we set out to investigate the presence of DAO and HMT in
ejaculates from different mammalian species.
Semen samples were collected from pig, cattle, horse, dog
and humans and seminal plasma and sperm cells were sep-
arated by centrifugation. DAO and HMT activities were
determined in seminal plasma from the pre-, main and post-
ejaculate and in homogenates of sperm cells using radio-
metric assays. DAO protein was analyzed in parallel samples
by Western blotting with specific antibodies. Total mRNA
was prepared from sperm cells and the expression of DAO
and HMT was analyzed by RT-PCR using specific primers.
DAO activity was measurable only in human seminal
plasma but not in seminal plasma from the other species tested
or in sperm cell homogenates. The presence of DAO in human
seminal plasma and its absence in the other samples was
confirmed by Western blotting with DAO specific antibodies.
HMT activity was not detectable in any of the samples ana-
lyzed. Neither DAO mRNA nor HMT mRNA was detectable
in total sperm cell RNA from any of the species.
From these results we conclude that DAO is present in
human seminal plasma but not in seminal plasma from
other mammals or in sperm cells. Human seminal plasma
DAO is likely to originate from the prostate gland or the
testis where DAO expression is detectable at the mRNA
level. HMT appears not to be present in mammalian sperm.
The presence of DAO only in human seminal plasma is an
interesting finding whose functional importance in the
fertilization process with respect to histamine and possibly
polyamine inactivation remains to be determined.
This study was supported by COST Action BM0806
(STSM-BM0806-8460).
Department of Veterinary Sciences, Institute of Animal
Physiology, Faculty of Veterinary Medicine, Ludwig-
Maximilians-Universität München, Veterinärstraße 13/A,
80539 München, Germany. E-mail: f.ahrens@tiph.vet-
med.uni-muenchen.de
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HISTAMINE IN PAROXYSMAL ATRIAL
FIBRILLATION (AF): RESULTS FROM
AN UNSELECTED POPULATION AT A TERTIARY
UNIVERSITY EMERGENCY UNIT
M. Raithel, C.M. Layritz, A.F. Hagel, M.F. Neurath,
W.G. Daniel, D. Ropers
Since its discovery in 1910 several cardiac effects have
been described for the biogenic amine histamine, including
chronotrophic effects, vasodilation of coronary arteries,
induction of arrhythmia etc. The present study investigated
plasma histamine levels in patients with paroxysmal atrial
fibrillation.
From 40 patients with paroxysmal atrial fibrillation,
blood was drawn immediately after entry into the emer-
gency unit before application of any therapy. Blood was
stored on ice and centrifuged within 10 min for plasma
histamine detection (IBL Hamburg). Plasma histamine was
determined in duplicate and compared with 20 non-allergic
controls and is expressed as ng histamine/ml 9 m2 body
surface area (BSA).
Plasma histamine in controls was 0.24 ± 0.11
(mean + SD) with a median of 0.26 (0.17–0.32; 25–75th
percentile, Gaussian distribution). Thus, the normal range
of plasma histamine levels was calculated as mean + 2SD
with \0.46.
Patients with AF did not significantly differ from con-
trols, but showed a higher mean plasma histamine level of
0.52 ± 0.74 with a median of 0.31 (0.19–0.45). Interest-
ingly, 8 of the 40 patients with AF (20.0 %) exceeded the
normal range of plasma histamine levels ([0.46) when
admitted to the emergency unit.
Among patients with paroxysmal AF a subpopulation
of individuals could be detected with significantly ele-
vated plasma histamine levels at admission. Thus, it
might be considered that elevation of systemic or cardiac
histamine levels may induce or provoke acute AF in
these patients. Application of H1- and H2-antihistamines
was beneficial in single patients to restore a regular sinus
rhythm and further investigations have to focus on the
etiology of plasma histamine elevations in this subpop-
ulation (e.g. acute-, chronic elevations, allergic or
inflammatory causes etc.)
Department of Medicine 1, University Erlangen,
Ulmenweg 18, 91054 Erlangen, Germany. E-mail: martin.
raithel@uk-erlangen.de
MAST CELLS, ENDOTHELIAL PROLIFERATION
AND CAPILLARY TUBE FORMATION
IN MYOCARDIUM OF PATIENTS
WITH END-STAGE PRIMARY DILATED
OR ISCHEMIC CARDIOMYOPATHY
M. Mussur, A. Stasiak, J. No _zyński, M. Zembala, J. Kobos,
W.A. Fogel
Inflammation is an important component in the pathogen-
esis of many common cardiovascular diseases including
ischemic (ICM) and primary dilated (PDCM). The mast
cell has established position as a source of inflammatory
and pro-proliferative mediators.
The study aim was to examine whether there are dif-
ferences in the number and distribution of mast cells and in
their relation to capillary endothelial proliferation and
capillary tube formation in myocardium and subendocar-
dial layer of patients with end-stage PDCM versus ICM.
Myocardial specimens, without degeneration or tissue
necrosis, from the anterior wall of 26 heart recipient
patients (14 ICM, 12 PDCM) were obtained. H&E staining
and immunohistochemistry, using anti-mast cell tryptase
and anti-CD31, were employed. Quantitative analysis of
the protein expression was performed by the MultiScan
Base v.8.08 Image Analysis System. Tryptase-positive
mast cells number and area, CD31-positive capillary
endothelium area and capillary lumen were estimated in
myocardium and subendocardial layer in 65.739 lm2
microscopic field. Values are presented as mean ± SD. For
statistical evaluation, U Wilcoxon–Mann–Whitney test and
Spearman range correlation coefficient were applied.
In myocardia of patients with end-stage PDCM, in
comparison with ICM patients, an increased numerical
density (0.51 ± 0.14 vs. 0.32 ± 0.16) and area
(44.33 ± 15.41 vs. 29.71 ± 13.98 lm2) of mast cells and
excessive capillary endothelial cells proliferation with
defect of capillary tube formation, respectively, was found.
Microvessel lumen and endothelium areas quotients were
in PDCM always below 1 (0.53 ± 0.26), while above 1
(2.79 ± 1.53) in ICM patients. CD31-positive endothelium
area correlated with tryptase-positive mast cell area in both
groups. No differences were found in mast cell density in
subendocardial layer.
This preliminary study suggests that the mast cells in
myocardium may be responsible for excessive capillary
endothelial proliferation in tandem with defects of capillary
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tube formation, as expressed by undeveloped lumen in
primary dilated versus ischemic cardiomyopathy patients.
These observations may have therapeutic significance.
COST Action BM1007 is acknowledged.
Cardiosurgery Department, Medical University of Lodz,
Sterlinga 1/3, 91-425 Lodz, Poland. E-mail: lahu@lahu.
com.pl
INVOLVEMENT OF THE CENTRAL
HISTAMINERGIC SYSTEM IN THYROTROPIN
RELEASING HORMONE-INDUCED
RESUSCITATING EFFECT IN HAEMORRHAGIC
SHOCK IN RATS
J. Jochem
Thyrotropin releasing hormone (TRH), apart from the role in
hypothalamus-pituitary-thyroid axis, influences many
functions of the central nervous system, including cardio-
vascular regulation. Intravenously (iv) administered TRH
evokes the resuscitating effect in haemorrhage-shocked rats,
with increases in mean arterial pressure (MAP), pulse pres-
sure (PP) and heart rate (HR). The mechanism of the effect is
associated with the activation of brain cholinergic neurons
and central muscarinic receptors. Interestingly, recent in
vitro studies by the group of Haas and Sergeeva demonstrate
excitation of histaminergic neurons of the tuberomamillary
nucleus (TMN) by TRH. Since we revealed previously the
resuscitating effect resulting from central histaminergic
system activation, and immunohistochemical analysis
showed TRH type 2 receptors within TMN neurons, the aim
of this study was to examine an involvement of the hista-
minergic system in TRH-evoked effects in haemorrhagic
shock. Experiments were carried out in ketamine/xylazine-
anaesthetised male Wistar rats (n = 6 in all groups), sub-
jected to haemorrhagic hypotension, with MAP stabilized at
20–25 mmHg, which resulted in the death of all control
animals within 30 min. TRH (3 mg/kg) given iv at 5 min of
critical hypotension evoked long-lasting increases in MAP,
PP and HR, with a 100 % survival at 2 h. Haemodynamic
effects observed 40 min after treatment, but not the survival
rate at 2 h, were significantly decreased by intracerebro-
ventricular pretreatment with histamine H1 receptor
antagonist chlorpheniramine (50 nmol), but not with raniti-
dine (50 nmol), clobenpropit (42.5 nmol) and JNJ 10191584
(25 nmol)—H2, H3 and H4 receptor antagonists, respec-
tively. Thus, these results demonstrate for the first time the
involvement of the histaminergic system in TRH-induced
resuscitating effect in haemorrhagic shock in rats.
Department of Basic Medical Sciences, Medical Uni-
versity of Silesia, Piekarska 18, 41-902 Bytom, Medical
University of Silesia, Katowice, Poland. E-mail: jjochem@
poczta.onet.pl
HISTAMINE H3 RECEPTOR REGULATES
THE FUNCTIONS OF THE PANCREATIC b-CELL
T. Nakamura, T. Yoshikawa, N. Noguchi, F. Naganuma,
R. Harada, A. Mohsen, K. Yanai.
Histamine and its receptors in the central nervous system play
important roles in energy homeostasis by modulating appetite
and satiety. However, the effects of histamine on pancreatic
b-cells in the islets of Langerhans, which secrete insulin to
maintain glucose homeostasis, had not been elucidated.
First, we found that histamine H3 receptors (H3R) are
expressed on rodent and human pancreatic b-cells. Next,
we examined the role of H3R in glucose-induced insulin
secretion (GIIS) from MIN6 cells, a cell line derived from
mouse pancreatic b-cells. The inhibitory effect of H3R on
GIIS was assessed pharmacologically using the specific
agonist, imetit. H3R signaling inhibited insulin granule
exocytosis, the final step in GIIS, but did not affect
upstream events in GIIS such as increases in intracellular
ATP and Ca2+ concentrations.
We found that the activation of H3R with imetit also
attenuated BrdU incorporation in MIN6 cells by 33 %. We
examined which factors were involved in the H3R-mediated
inhibition of b-cell proliferation. Imetit decreased the
phosphorylation of cyclic AMP response element binding
protein (CREB), one of the essential transcriptional factors
for b-cell proliferation. Thus, H3R signaling likely regulates
b-cell proliferation by decreasing CREB phosphorylation.
Overall, these lines of evidence suggest that H3R
expressed in b-cells may play a pivotal role in energy
homeostasis by regulating insulin secretion and b-cell
proliferation. Therefore, H3R could be a diagnostic and/or
therapeutic target in diabetic patients.
Department of Pharmacology, Tohoku University,
Graduate School of Medicine, Sendai, 980-8575, Japan.
E-mail: yanai@med.tohoku.ac.jp
EXOGENOUS SALSOLINOL ACTS ON MAST
CELLS AND INTERSTITIAL CELLS OF CAJAL
IN THE RAT JEJUNUM
M. Kurnik, K. Gil, A. Bugajski, P. Thor
Mast cells (MC) and interstitial cells of Cajal (ICC)
develop close spatial contacts in the gastrointestinal (GI)
tract. Intestinal motility disturbances are frequently asso-
ciated with a reduced number of ICC as well as with
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immune cell infiltration. Salsolinol (1-methyl-6,7-dihy-
droxy-1,2,3,4-tetrahydroisoquinoline) is an endogenous
agent primarily formed from aromatic amine precursors by
an enzymatic or a non-enzymatic pathway leading to
neurotoxic N-methyltetrahydroquinolinium ions, which
may play a role in the etiology of Parkinson’s disease (PD).
Gastrointestinal dysmotility observed in PD patients may
partly be due to peripheral effects of salsolinol. The aim of
this study was to evaluate the chronic effects of salsolinol
on MC and ICC in the jejunum of rats.
Salsolinol (200 mg/kg in total) was continuously
administered to male Wistar rats using intraperitoneal
ALZET (Durtec, USA) osmotic mini-pumps for 2 weeks
(delivery rate 0.5 lL/h, n = 4) or 4 weeks (delivery rate
0.25 lL/h, n = 4). Sham animals implanted with mini-
pumps delivering saline (n = 8) served as the controls. At
the end of the experiment, animals were decapitated and
segments of jejunum were removed. Longitudinal muscle–
myenteric plexus preparations (LMMP) were double-
stained with anti-c-Kit polyclonal antibody (Dako, USA)
and anti-tryptase polyclonal antibody (Dako, USA).
The number of cells stained with both anti-c-Kit and
anti-tryptase (i.e., MC) in the GI wall was decreased in
both salsolinol-treated groups compared to the control
group. However, the number of degranulated MC was
elevated in both salsolinol-treated groups compared to the
control group. The number of cells stained with anti-c-Kit
only (i.e., ICC) was lower in both salsolinol-treated groups
in comparison with the control group.
In our model, chronic, intraperitoneal administration of
salsolinol damages MC and ICC. We speculate that this
may lead to an impairment of GI function.
Department of Pathophysiology, Medical College Jag-




THE PROGRESSION OF PERIODONTAL DISEASE
IN RAT EXPERIMENTAL PERIODONTITIS
J.P. Prestifilippo, E. Carabajal, M. Croci,
J. Fernández-Solari, E.S. Rivera, J.C. Elverdin,
V.A. Medina
We have recently reported that experimental periodontitis
reduced methacholine-induced submandibular gland
(SMG) salivary secretion. The aim of the present study was
to determine whether histamine could prevent SMG
impairment produced by experimental periodontitis.
Bilateral experimental periodontitis was induced in male
rats by placing a cotton thread ligature around the neck of
both first lower molars for 2 weeks; and histamine treat-
ment (0.1 mg/kg, s.c.) was initiated 5 days before the end
of the experimental period. The effects of histamine on
periodontitis-altered functional and histological parameters
of SMG and on periodontal bone loss were evaluated in 48
animals (n = 12 each group).
Histamine treatment partially reversed the reduction in
methacholine-induced salivation produced by experimental
periodontitis while preventing SMG histological damage.
The effect of histamine on SMG was associated with
an increased proliferation rate (2.2 ± 0.3 vs. 0.2 ± 0.2
proliferative cells per field evaluated by PCNA immuno-
reactivity, P \ 0.001). Furthermore, histamine completely
prevented the increase in apoptosis associated with exper-
imental periodontitis (1.0 ± 0.4 vs. 60.9 ± 4.6 apoptotic
cells per field evaluated by the TUNEL assay, P \ 0.001).
The protective effect of histamine on SMG functionality
was associated with attenuation of lingual and vestibular
bone loss (0.66 ± 0.04 vs. 0.97 ± 0.06 mm; P \ 0.001)
and a reduction of increased levels of prostaglandin E2 in
gingivia of rats with experimental periodontitis.
Based on the evidence presented, we conclude that
histamine is able to reduce periodontitis-induced damage to
the SMG and bone structure. Although further studies are
needed to fully understand the role of histamine in peri-
odontal disease, the present results suggest that this
compound deserves to be studied as a potential agent to
diminish periodontitis in a prospective study.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Junı́n 956 PB,
1113, Buenos Aires, Argentina. E-mail: vmedina@ffyb.
uba.ar
RADIOPROTECTIVE POTENTIAL OF HISTAMINE
ON RAT SMALL INTESTINE AND UTERUS
E. Carabajal, N. Massari, M. Croci, D. Martinel Lamas,
J.P. Prestifilippo, R.M. Bergoc, E.S. Rivera, V.A. Medina
Based on our previous data which showed the histamine
radioprotective effect on mouse small intestine, bone
marrow and salivary glands, in the present work we aimed
to improve our knowledge about the histamine radiopro-
tective potential by investigating its effect on reducing
ionising radiation-induced injury in the rat small intestine
and uterus. Rats were divided into 4 groups. Histamine and
histamine-5 Gy groups received a daily subcutaneous
histamine injection (0.1 mg/kg) starting 24 h before irra-
diation. Histamine-5 Gy and untreated-5 Gy groups were
irradiated with a dose of whole-body Cesium-137
S84 The European Histamine Research Society
123
irradiation. Three days post irradiation animals were sac-
rificed and tissues were removed, fixed, stained with
haematoxylin and eosin and histological characteristics
were evaluated. Proliferation and apoptosis markers were
studied by immunohistochemistry. Results demonstrate
that histamine treatment reduced radiation-induced muco-
sal atrophy, oedema and vascular damage produced by
ionising radiation, increasing the number of crypts per
circumference (239 ± 12 vs. 160 ± 10, P \ 0.01). This
effect was associated with a reduction of radiation-induced
intestinal crypts apoptosis. Furthermore, radiation-induced
flattening of the endometrial surface, depletion of deep
glands and reduced mitosis, effects that were completely
blocked by histamine treatment. The expression of a pro-
liferation marker in uterine luminal and glandular cells was
markedly stimulated in histamine treated and irradiated
rats. The evidence indicates that histamine is a potential
candidate as a safe radioprotective agent that may increase
the therapeutic index of radiotherapy for intra-abdominal
and pelvic cancers. However, its efficacy needs to be
carefully investigated in prospective clinical trials.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Junı́n 956 PB,
1113, Buenos Aires, Argentina. E-mail: vmedina@ffyb.
uba.ar
Src PROTEIN INVOLVEMENT IN HISTAMINE:
INDUCED MDA-MB-231 CELLS MIGRATION
N. Mohamad, J. Porretti, P. Girardi, C. Cocca, E. Rivera,
G. Cricco, G. Martı́n
We have previously demonstrated that cell migration and
invasion of human breast carcinoma MDA-MB-231 cells
were stimulated by low doses (0.5–1 lM) of histamine
(HA), while inhibited by concentrations greater than
10 lM. These opposite actions are mediated by different
intracellular hydrogen peroxide (H2O2) levels. c-Src pro-
tein is activated by phosphorylation and this is critical for
cell migration and cancer progression to metastasis. This
protein phosphorylates substrates such as beta-catenin
which translocates to the nucleus and modulates the
expression of genes related to the epithelial mesenchymal
transition (EMT). The aim of this work was to study the
role of the c-Src protein in HA-induced migratory response
of MDA-MB-231 cells.
We used a c-Src specific inhibitor, PP2, in a concen-
tration which had no effect on cell proliferation. 1 lM PP2
blocked the stimulatory action of low doses of HA in cell
migration and invasion as determined by transwells units
coated or not with matrigel. PP2 also blocked increase in
further EMT markers (gelatinolytic activity and alpha
smooth muscle actin expression) induced by 1 lM HA. An
increase in c-Src phosphorylation was observed by western
blot with 1 lM HA or exogenous 0.5 lM H2O2 while a
decrease was registered when HA was [10 lM or 5 lM
H2O2 were used. Catalase treatment reversed those effects.
The expression of beta-catenin protein was evaluated by
immunostaining and Western blot. There was a higher
nuclear and perinuclear expression with 1 lM HA. Con-
versely, the combined treatment of 1 lM HA plus 1 lM
PP2 produced a cytoplasmic and nuclear beta catenin
expression similar to non-treated cells. Low doses of HA
also inactivated GSK-3beta, an enzyme involved in cyto-
plasmic degradation of beta catenin, favoring its nuclear
translocation.
In summary, our results indicate that HA modulates the
migratory and invasive capacity of MDA-MB 231 cells
through a singular GPCR signaling pathway involving a
H2O2-induced c-Src phosphorylation.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Argentina.
National Research Council. Junin 954, Buenos Aires, 1113,
Argentina. E-mail: gamartin@ffyb.uba.ar
HISTAMINE AND CLOZAPINE TREATMENTS
INHIBIT TUMOUR GROWTH AND INCREASE
MEDIAN SURVIVAL IN HUMAN MELANOMA
XENOGRAFT MODEL
N. Massari, V.A. Medina, M. Croci, L. Sambuco,
D. Martinel Lamas, R.M. Bergoc, E.S. Rivera
Melanoma accounts for less than 5 % of skin cancer cases
but causes a large majority of skin cancer deaths. The
expression of all histamine receptor (HR) subtypes was
demonstrated in human melanoma cell lines, and the acti-
vation of H4R in WM35 primary and M1/15 highly
metastatic human melanoma cells inhibits proliferation and
migration, and induces differentiation and senescence. The
aim of this work was to evaluate the in vivo anti-tumour
potential of histamine (HA) and clozapine (CLZ, H4R
agonist) on human melanoma. An experimental model was
developed by subcutaneous (sc) injection of M1/15 cells
into the right flank of athymic nude mice. Animals were
separated into three groups: control, HA (1 mg.kg-1, sc)
and CLZ (1 mg.kg-1, sc). After spontaneous death,
tumours were excised and the expression levels of H4R,
HA and histidine decarboxylase (HDC) were studied by
immunohistochemistry. Cell growth was assessed by
PCNA expression and by mitotic index (MI). Finally,
vascularization was determined by Massons trichromic
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staining and invasion markers by metalloprotease (MMP-2
and MMP-9) expression levels. Mice receiving HA or CLZ
showed a median survival increase (61 days) verus control
group (40 days) treated with saline solution (p \ 0.05).
Tumour volumes after 70 days of HA (2.7 cm3) or CLZ
(3.0 cm3) treatment were significantly lower than in control
mice (12.8 cm3) (p \ 0.01). Treatment with HA
(12.8 ± 4.3 days) or CLZ (13.8 ± 4.3 days) increases
tumour doubling time versus control group (5.0 ± 1.1
days), p \ 0.05. PCNA, MI, intra-tumoral neovasculari-
zation and the expression of MMP-2 and MMP-9 were
diminished in HA and in CLZ treated mice, while the
expression of H4R, HA and HDC seemed not to be mod-
ified. We conclude that HA and CLZ show an anti-tumour
effect in human melanoma. Further studies are needed to
corroborate the importance of H4R as a potential target for
new drug development for the treatment of this disease.
Laboratorio de Radioisótopos, Facultad de Farmacia y
Bioquı́mica, Universidad de Buenos Aires, 1113, Buenos
Aires, Argentina. E-mail: erivera@ffyb.uba.ar
HISTAMINE INACTIVATING ENZYMES
IN BREAST CANCER CELL LINES
D. Martinel Lamas, H.G. Schwelberger, E.S. Rivera,
V.A. Medina
There is increasing evidence to demonstrate that histamine
plays a significant role in breast cancer progression since
functional histamine receptors and L-histidine decarboxyl-
ase activity are present in breast tissue. In addition,
histamine is increased in plasma and cancerous tissue
derived from breast cancer patients compared to healthy
subjects. As the importance of histamine catabolism has
not been fully studied in breast cancer cells, the aim of the
present work was to investigate the expression and activity
of the histamine inactivating enzymes diamine oxidase
(DAO) and histamine N-methyltransferase (HMT) in two
breast cancer cell lines (MDA-MB-231 and MCF-7) with
different malignant characteristics. Furthermore, we eval-
uated whether histamine treatment could modulate cell
expression and activity. The expression of these two
enzymes was determined by RT-PCR and western blot
while the activity was measured by a radiometric assay.
Results show that DAO was not detected in either cell line
either at the mRNA or protein level. However, HMT
enzyme was expressed in MDA-MB-231 and MCF-7 cells.
In agreement with these results, DAO enzyme activity was
not observed while HMT activity was detected in both cell
lines. Histamine induced a down-regulation of the HMT
activity, exhibiting a threefold decrease in MDA-MB-231
and MCF-7 cells (P \ 0.0001). We conclude that HMT is
the only histamine inactivating enzyme detected, suggest-
ing a crucial role of this enzyme in histamine catabolism in
breast cancer.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Junı́n 956 PB,
1113, Buenos Aires, Argentina. E-mail: vmedina@ffyb.
uba.ar
HISTAMINE ACTIONS IN THE NORMAL HUMAN
FIBROBLAST CELL LINE CCD-1059Sk
J. Porretti, N. Mohamad, E. Badenas, M. Esnaola,
E. Rivera, G. Martı́n, G. Cricco
We have previously demonstrated a high expression of
histidine decarboxylase (HDC), the enzyme involved in
histamine (HA) synthesis and therefore a high HA content
in the human pancreatic carcinoma cell line BxPC3. In vivo,
HA produced a significant desmoplasia in nude mice
bearing BxPC3 xenografts and also neoplastic cells colo-
nizing lung parenchyma were observed. In vitro,
conditioned medium of BxPC3 cells treated with HA
(1–10 lM) increased the number of CCD-1059Sk cells in S
phase of the cell cycle. The aim of this work was to evaluate
HA action on cell proliferation, gelatinase expression and
activity and cell motility in the normal human fibroblast cell
line CCD-1059Sk. A direct action of HA (1–10 lM) on
fibroblast proliferation was observed employing a bromo-
deoxyuridine (BrdU) incorporation technique. After 8 h of
HA treatment there was a significant rise in number of
fibroblast cells in S phase (p \ 0.05 vs. non-treated cells).
By RT-PCR, we detected mRNA expression of H1, H2 and
H4 histamine receptors, the matrix metalloproteinase 2
(MMP2) and the tissue inhibitor of MMP (TIMP1) in this
cell line. Immunostaining studies showed that CCD-1059Sk
fibroblasts expressed cytoplasmic MMP2 protein, although
no difference in MMP2 expression was observed between
HA treated and non-treated cells. Gelatinolytic activity
evaluated by zymography was significantly increased by
10 lM HA (195 % vs. control, p \ 0.001) and reproduced
by 10 lM H1 histamine receptor agonist 2-((3-trifluoro-
methyl)phenyl) histamine dimaleate (190 % vs. control,
p \ 0.001). 10 lM HA enhanced cell migration (p \ 0.05
vs. non treated cells) assessed using transwell units. In
summary, we may conclude that exogenous HA exerts
a direct action on CCD-1059Sk cell proliferation,
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gelatinolytic activity and motility, opening the perspective
for future studies on the role of histamine in fibroblast
activation during the epithelial mesenchymal transition
related to cancer progression.
Laboratory of Radioisotopes, School of Pharmacy and
Biochemistry, University of Buenos Aires, Argentina. Junin
954, Buenos Aires, 1113, Argentina. E-mail: gracrico@
ffyb.uba.ar
MODULATION BY HISTAMINE OF b2
ADRENOCEPTOR-MEDIATED cAMP
ACCUMULATION IN COS-7 CELLS: A POSSIBLE
ALLOSTERIC ACTION
D.A. McNaught-Flores, M.A. Soriano-Ursúa,
J.A. Arias-Montaño
Our previous data suggested an allosteric action of hista-
mine to modulate cAMP formation induced by the
activation of b2 adrenoceptors endogenously expressed by
human prostate cancer cells DU-145. In this work we have
studied further this issue by combining functional assays
with heterologously expressed human b2 adrenoceptors
(hb2-ARs) and molecular modeling.
In COS-7 cells transiently transfected with the hb2-AR
(10.4 ± 1.1 pmol/mg protein), incubation with histamine
had no effect on basal cAMP accumulation but enhanced
the response to the b-AR agonist isoproterenol (153 ±
15 % of control response) in a concentration-dependent
manner (EC50 6.2 lM, pEC50 5.21 ± 0.24). In contrast,
the inhibition by isoproterenol of [3H]-dihydroalprenolol
binding was not modified by histamine (pKi 5.99 ± 0.20
and 5.95 ± 0.10 in the presence and the absence of 10
lM histamine, respectively). Modeling on the hb2-AR
showed the presence of three sites capable to bind imi-
dazol-contaning drugs, and two of these sites had
theoretical affinities (2–3 lM) in the range of histamine
modulation of cAMP accumulation observed in transfec-
ted cells.
Taken together, these data provide further support for an
allosteric action of histamine to modulate the intracellular
signaling of human b2 adrenoceptors.
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